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ABSTRACT
Impact of Diabetes on Colorectal Cancer Outcomes
Neel A. Shah
Diabetes is one of the most common chronic comorbid condition seen in elderly CRC patients.
Outcomes of CRC patients with diabetes specifically stage at diagnosis, emergency condition for
CRC surgery, survival, and mortality have been insufficiently explored. The aims of the study
were to investigate the association between diabetes and stage at diagnosis of CRC in elderly
Medicare beneficiaries; to check the association of diabetes with presenting as an emergency
condition for CRC surgery in the elderly and; to explore the effect of diabetes on survival of
elderly Medicare beneficiaries with CRC. Using the SEER-Medicare data from 2003-2005,
patients newly diagnosed with CRC were selected and divided into diabetic and nondiabetic
cohorts. The two cohorts were compared in terms of stage at CRC diagnosis, emergency
presentation for CRC surgery, and five year survival. Logistic regressions were used to check the
association between diabetes and stage at diagnosis and emergency condition for CRC surgery.
Survival analysis was employed compare time to death between diabetic and non-diabetic CRC
patients. Covariates used in the study included the three most common comorbid conditions
besides diabetes: coronary atherosclerosis, congestive heart failure, and chronic obstructive
pulmonary disease, age, sex, race, tumor location, region in the country, patient location, and
frequency of physician office visits. For survival analysis additional treatment variables –
chemotherapy, radiation, and surgery were included. For stage at diagnosis of CRC, diabetes
showed a significant inverse association (OR 0.92; 95% CI 0.85-1.00). On adding quintile of
physician office visits this association was not significant. Odds of being diagnosed at a later
stage was significantly associated with the least number of office visits (OR 2.13; 95% CI 1.862.44) as was having a proximal tumor (OR 1.40, 95% C 1.30-1.51) Although the odds of a
diabetic patient being an emergency patient were lower than a non-diabetic, this was not
statistically significant (OR 0.89; 95% CI 0.79-1.01) Mortality risk was significantly greater for
diabetic CRC patients than nondiabetics (HR 1.15, 95% CI 1.09-1.20). Presenting emergently
increased the risk of mortality (HR 1.61, 95% CI 1.54-1.68). Surgery for CRC reduced the risk
of mortality (HR 0.41, 95% CI 0.39-0.43) and although in bivariate analyses patients who
received chemotherapy were more likely to die, the hazard model showed a significant benefit
associated with chemotherapy or radiation (HR 0.70, 95% CI 0.67-0.74). The worse terminal
outcomes seen in diabetic CRC patients indicates the need for early and timely screening to
prevent the disease or diagnosis at earlier stages.
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CHAPTER ONE
INTRODUCTION
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Colorectal cancer (CRC) is the third most common form of cancer after prostate/breast
and lung cancer in men and women in the United States (Ahuja, Chang, & Gearhart, 2007)
(Jemal, Siegel, Ward, Hao, Xu, & Thun, 2009). In 2011 approximately 141,210 men and women
were expected to be diagnosed and approximately 49,380 are expected to succumb to CRC The
incidence of CRC is uncommon under the age of 50 years and younger patients’ tumors are
thought to predominantly be induced by heredity in those with a family history (Rim, Seeff,
Ahmed, King, & Coughlin, 2009). However, the incidence of colorectal adenomas, which are
precursors to the cancer, rises with age and two thirds of all CRC occur in patients over the age
of 65 (Holt, Kozuch, & Mewar, 2009).
Although a definitive causal factor for CRC has not been identified, several risk factors
have been hypothesized to lead to the cancer. These include family history and genetics,
increasing age, male sex, previous colonic adenomas, and environmental factors such as
consumption of red meat, high-fat diet, inadequate intake of fiber, sedentary lifestyle, smoking,
high consumption of alcohol, diabetes mellitus and obesity (Centers for Disease Control and
Prevention). A review of several studies with diverse endpoints and in diverse populations has
shown that insufficient vitamin D has a causal association with CRC (Giovannucci E. , 2010).
Inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease have also proven to
be strongly associated with CRC, with one meta-analysis showing high a odds ratio (2.59) of
developing CRC in Crohn’s disease patients (von Roon, Reese, Teare, Constantinides, Darzi, &
Tekkis, 2007) (Eaden, Abrams, & Mayberry, 2001).
Early stage CRC can be asymptomatic. Symptoms that may appear as the cancer
progresses include blood (either bright red or very dark) in the stool; diarrhea, constipation, or
feeling that the bowel does not empty completely; stools that are narrower than usual; frequent
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gas pains, bloating, fullness, or cramps; unexplained weight loss; fatigue; and nausea and
vomiting. However, these symptoms are common to various other diseases/conditions and only
pathologic abnormalities observed during screening for colorectal adenomas or tumors can
confirm a diagnosis of cancer.
Staging of CRC is based on the TNM (Tumor, Node, Metastases) classification. Most
colorectal cancers start off as adenomatous polyps that turn into adenocarcinomas (cancers that
begin in cells that make and release mucus and other fluids). TNM classification is followed by
staging which is linked to the survival rates as shown in Tables 1 and 2.
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Table 1. TNM Classification of Colorectal Cancer
T=primary tumour

N=regional lymph nodes

M=distant metastasis

TX=primary tumour cannot be assessed

NX=regional lymph nodes cannot

MX=distant metastasis

be assessed

cannot be assessed

N0=no regional lymph node

M0=no distant metastasis

T0=no evidence of primary tumour

metastasis
Tis=carcinoma in situ: intraepithelial or

N1a=metastasis in one regional

M1a=distant metastasis to

invasion of lamina propria

lymph node

one site

T1=tumour invades submucosa

N1b=metastasis in two to three

M1b=distant metastasis to

regional lymph nodes

more than one site

T2=tumour invades muscularis propria

N2a=metastasis in four to six
regional lymph nodes

T3=tumour invades through the muscularis

N2b=metastasis in seven or more

propria into subserosa or into

regional lymph nodes

nonperitonealised pericolic or perirectal
tissues
T4a=tumour penetrates the surface of the
visceral peritoneum
T4b=tumour directly invades or is
histologically adherent to other organs or
structures

Source: (Gunderson, Jessup, Sargent, Greene, & Stewart, 2010)
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Table 2. Colorectal Cancer staging based in TNM Classification

TNM staging

Stage I

Stage II

Stage III

Stage IV

T1 N0 M0

A: T3 N0 M0

A: T1-2 N1 M0

Any T Any N M1

T2 N0 M0

B: T4 N0 M0

B: T3-4 N1 M0
C: Any T N2 M0

Definition

Invades submucosa

Invades subserosa,

Involves 1-3 (N1) or

Involves distant

(T1)/muscular

nonperitonealized

more (N2) lymph

metastases

propria (T2)

pericolic/perirectal

nodes

tissues (T3). Invades
other organs or
structures/visceral
peritoneum (T4)
Surgery

Usual
Treatment

Surgery with or

Surgery with

Chemotherapy with

without

chemotherapy

or without surgery

57%

6%

chemotherapy
95%

5-year

82%

Survival, 19901999
Source: (Gloeckler Ries, Reichman, Lewis, Hankey, & Edwards, 2003)

As many as 50% of the Western population develops adenomatous polyps in their
lifetime but the lifetime risk for colon cancer is about 5% and only one in ten adenomas lead to
cancer formation (Holt, Kozuch, & Mewar, 2009). It cannot be determined which individuals
with adenomas (or a histologically normal colon at risk for adenoma and cancer formation) will
develop a cancer, and therefore, preventive methods use detection and removal of benign
neoplastic colorectal adenomas to lower colon cancer formation and mortality (Muller &
5

Neel Shah

Dissertation

Sonnenberg, 1995). Timely screening can lead to early detection of the cancer, better prognosis
of the disease and improved observed survival rates (Miller, 2008). The advantage that CRC
screening has over screening for other types of cancer is that with the appropriate test it can
detect and remove cancer precursors, such as, adenomatous polyps, to decreased the incidence
(Mandel, Bond, & Church, 2000).

Elderly and CRC
The incidence of CRC increases with age and almost two-thirds of CRC cases occur in
individuals over the age of 65. Molecular and pathophysiological evidence as to why there is an
increase in CRC incidence with age in humans is vague (Holt, Kozuch, & Mewar, 2009).
Relative survival rates from 1996-2000 have shown no significant difference between age groups
up to 75 years, however after the age of 75 there is a decline in survival rates (Ries, Melbert,
Krapcho, Stinchcomb, Howlader, & Horner, 2007). Although the overall incidence and mortality
is similar in both sexes, the age specific incidence is greater in men. Colorectal adenomas and
cancer appear several years later in women probably due to protection by estrogen/progesterone.
Some studies have shown that postmenopausal estrogen/progesterone hormone treatment in
women can lower colorectal neoplasia risk by as much as 30% (Johnson, et al., 2009)
(Chlebowski, et al., 2004 ). Comorbidity, or illness other than the primary illness under
treatment, is more common in the elderly (Shack, Rachet, Williams, Northover, & Coleman,
2010 ). Older individuals also often present with chronic conditions that complicate the
diagnostic and clinical management of CRC which leads to poorer prognosis and outcomes of
the cancer (Yancik, et al., 1998 ) (Satariano & Silliman, 2003). The three most common
comorbid conditions with CRC seen in elderly patients are congestive heart failure, chronic
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obstructive pulmonary disease and diabetes mellitus (Gross, Guo, McAvay, Allore, Young, &
Tinetti, 2006 )

Diabetes and CRC
There is a large body of literature contributing to evidence about the association of
diabetes mellitus with CRC. Most studies exploring the relationship between diabetes and CRC
have studied type 2 diabetes mellitus or have not separated type 1 and type 2 diabetes.
Epidemiological studies that have included type 1diabetes have not found a significant
association between type 1 diabetes and CRC (Wideroff, et al., 1997) (Zendehdel, Nyrén,
Ostenson, Adami, Ekbom, & Ye, 2003). One of the first studies to document a high occurrence
of diabetes mellitus in patients with colon cancer was published in 1984 by Williams and
colleagues (Williams, Walsh, & Jackson, 1984). Their observation of excessive simultaneous
occurrence of diabetes mellitus in patients with colon cancer in a private clinic was documented
by a retrospective review of records in the clinics and their associated community hospital.
The first Cancer Prevention Study of the American Cancer Association, initiated in 1959,
was a large prospective epidemiological study of colorectal cancer incidence in diabetic patients
(Will, Galuska, Vinicor, & Calle, 1998). After following diabetics for 13 years and adjusting for
known cancer risk factors they found that the increased risk of developing CRC compared to
non-diabetics was 30% in men and 16% in women. Several subsequent prospective studies have
come to the conclusion of increased risk of CRC in diabetic men and women (Wideroff, et al.,
1997) (Hu, et al., 1999) (Weiderpass, Gridley, Nyrén, Ekbom, Persson, & Adami, 1997 ). An
increased risk of CRC has also been reported in case-control studies by La Vecchia et al and Le
Marchand et al. (La Vecchia, Negri, Decarli, & Franceschi, 1997 ) (Le Marchand, Wilkens,
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Kolonel, Hankin, & Lyu, 1997). While La Vecchia reported an increased risk for rectal cancer
than colon cancer in diabetic patients, LaMarchand found that there was an increased risk of
developing a left-sided colon cancer whereas rectal cancer was greater in diabetic women than in
diabetic men. The National Health and Nutrition Survey I (NHANES I) collected extensive
baseline data via exam and questionnaire from 1971-1975 (Steeland et al, 1995). The subjects
who were aged 25-74 years at the time were followed through 1987 for mortality and disease
incidence via death certificate and hospital discharge data. For CRC results showed that for both
men and women diabetes posed the highest risk but lack of physical non-recreational physical
activity caused no increase in risk.
Following the growing epidemiological evidence of the association of diabetes with
CRC, McKeown-Eyssen and Giovannucci proposed what came to be popularly known as the
hyperinsulinemia hypothesis which suggested that high levels of insulin and glucose might be
risk factors for colorectal carcinogenesis (McKeown-Eyssen, 1994) (Giovannucci E. , 1995).
This hypothesis grew from trying to explain the link between colorectal cancer, diets high in fat
and low in vegetables, and obesity and from the observations that insulin promotes the growth of
colon cells in vitro and colon tumors in vivo. Hyperinsulinemia and hyperglycemia result from
the dysregulation of the interrelationship between insulin secretion and insulin action, which can
also eventually lead to the development of type 2 diabetes mellitus. CRC shares these risk factors
with diabetes mellitus and the hyperinsulinemia hypothesis has been furthered by suggesting that
because the onset of type 2 diabetes mellitus is characterized by insulin resistance, and in most
cases, with hyperinsulinemia for compensation there is an increased level of insulin in type 2
diabetes patients as well which, as a by-product, leads to a complex chain of events promoting
tumor growth in the colon (Jin, 2008). It also has been suggested that insulin is considered to be
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a growth factor and insulin receptors are observed in both normal as well as malignant colorectal
cancer cells; insulin receptors can be bound by insulin-like growth factors, factors which can be
expressed by colorectal cancers (Chang & Ulrich, 2003 ).
The influence of diabetes mellitus on the mortality of patients with established colorectal
cancer has been demonstrated by various authors but with conflicting conclusions. Results from
a clinical trial by Meyerhardt, et al. were the first to be documented in 2003 when it was found
that even after adjustment for other predictors of colon cancer, patients with diabetes and highrisk stage II or stage III colon cancer experienced a significantly higher rate of overall cancer
mortality and cancer recurrence than non-diabetics (Meyerhardt, et al., 2003 ). Only one other
prospective study in the United States has investigated this relationship finding a similar positive
association (Coughlin, Calle, Teras, Petrelli, & Thun, 2004). Retrospective studies have mixed
conclusions about whether or not pre-existing diabetes affects CRC mortality. A study conducted
in elderly patients in the Netherlands found that with co-morbidities such as diabetes, patients
were treated less aggressively and had a worse survival than those with no concomitant disease
(Lemmens, Janssen-Heijnen, Verheij, Houterman, & Repelaer van Driel, 2005). Other
retrospective cohort studies have concluded that diabetes did not affect short-term survival,
cancer specific survival or stage at diagnosis of CRC (Shonka, Anderson, Panwalkar, Reed,
Steen, & Ganti, 2006) (Jullumstrø, Kollind, Lydersen, & Edna, 2009). Poorly controlled type 2
diabetes independently predicts early onset of CRC, a more advanced stage at the time of
presentation and a poorer 5-year survival (Siddiqui, Spechler, Huerta, Dredar, Little, & Cryer,
2008 ). In a retrospective cohort study of Veterans’ Administration patients it was found that
diabetes prevalent with CRC did not affect overall survival in their sample which could be due to
excellent quality of diabetes care prior to and post cancer diagnosis (Chiao, Nambi, & Naik,
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2010). There exist only two studies that have studied mortality in CRC patients with pre-existing
diabetes in a large nationally representative sample (Coughlin, Calle, Teras, Petrelli, & Thun,
2004) (Gross, Guo, McAvay, Allore, Young, & Tinetti, 2006 ). Only the study by Gross et al was
a retrospective cohort analysis and included incident cases only till the year 1999.

Emergency Surgery for CRC
Surgical resection is the only curative treatment of colorectal cancer, performed as an
open, surgical procedure requiring hospitalization (Redaelli, Cranor, Okano, & Reese, 2003)
(Mitry, Barthod, Penna, & Nordlinger, 2002). Potentially fatal complications of colorectal
cancer include bowel perforation, peritonitis, and obstruction. These complications are
considered surgical emergencies and are the initial presentation of colorectal cancer in an
estimated 15% to 30% of patients with colorectal cancer (Diggs, Xu, Diaz, Cooper, &
Koroukian, 2007). In addition, patients with emergency room presentation of CRC have
increased 30-day mortality and decreased 5-year survival compared to those scheduled for
elective surgery (Mitchell, Inglis, Murdoch, & Porter, 2007 ). Other studies have found that
overall survival at 5 years was 57.5% after elective and 39.1% after emergency surgery for CRC
(McArdle & Hole, 2004). The Colorectal Cancer Collaborative Group in England examined how
the outcomes of surgery in elderly patients differ from those in younger patients finding that
elderly patients who had an increased frequency of comorbid conditions, were more likely to
present with later-stage disease and undergo emergency surgery, and less likely to have curative
surgery than younger patients (Colorectal Cancer Collaborative Group, 2000). Their systematic
review also found that the incidence of postoperative morbidity and mortality increased
progressively with advancing age. Performance of surgery in the presence of comorbid
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conditions especially in the elderly can significantly increase mortality (Lemmens, JanssenHeijnen, Verheij, Houterman, & Repelaer van Driel, 2005). A study conducted in the
Netherlands found that among patients with colorectal cancer, comorbidity in general,
cardiovascular diseases, COPD, venous thromboembolism and diabetes had a negative effect on
overall survival after surgery. Currently there are no retrospective cohort studies conducted in the
United States in the extant literature that compare the outcomes of emergency surgery for CRC
in patients with and without pre-existing diabetes.

Need for the Study
Several epidemiological studies have explored the outcomes of CRC in patients with preexisting diabetes. Long term mortality in CRC patients with diabetes has been shown to be
greater than in patients without diabetes by all studies. Although previously conducted
prospective cohort studies have controlled for bowel obstruction and bowel perforation, (i.e. an
emergency condition) they have had the disadvantage of not adjusting for other comorbid
conditions and including only high risk stage I and stage II CRC patients. Retrospective studies
that have been conducted in the United States largely suffer from small sample sizes or were
limited to studying a sample that were residents of a single state, and are therefore not
generalizable to a national population (Polednak A. P., 2006) (Siddiqui, Maddur, Naik, & Cryer,
2008 ). Some of these studies either had samples whose median age was less than 65 years or did
not exclusively focus on the elderly, who form two-thirds of all incident CRC cases, as
previously mentioned. The linked Surveillance, Epidemiology and End-Results (SEER)Medicare data are a large population-based source of information for cancer-related
epidemiologic and health services research. Till the year 1999 there were only 11 SEER areas
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that participated in the SEER program representing 14% of the US population (Warren,
Klabunde, Schrag, Bach, & Riley, 2002). With the addition of four more states, the SEER
program will cover 25% of the US population. Retrospective analysis looking at the outcomes of
CRC in patients with comorbid conditions such as diabetes using the SEER-Medicare database
has been conducted by one study which included patients representing only the 11 SEER areas
(Gross, Guo, McAvay, Allore, Young, & Tinetti, 2006 ). This study also did not adjust for
emergency presentation of CRC with bowel obstruction or bowel perforation.
Outcomes associated with emergency presentation of CRC have been explored by several
European studies. Only two studies have compared outcomes associated with emergency surgery
and elective surgery for CRC in the United States (Smothers, Hynan, Fleming, Turnage,
Simmang, & Anthony, 2003 ) (Kim, Mittal, Konyalian, King, Stamos, & Kumar, 2007). Both
studies were limited by their extremely small sample sizes (29 and 209 patients) and one study
failed to comprehensively adjust for variables such as comorbid conditions and stage at
presentation. Only one retrospective cross-sectional study of a nationally representative sample
has evaluated the predictors of emergency presentation for CRC. (Diggs, Xu, Diaz, Cooper, &
Koroukian, 2007) This study used hospitalized in-patient data for just one year and included the
non-elderly, uninsured patients with third-party payers other than Medicare and did not segregate
comorbid conditions. No other study exploring the predictors of emergency surgery has been
conducted in the United States nor has there been a retrospective population based analysis
comparing the likelihood of emergency CRC surgery in the diabetic elderly versus non-diabetic
elderly patients. In addition, there are no studies in the US which have looked at the differential
association of diabetes with stage at diagnosis in a large nationally representative population.
Studies in other parts of the world show mixed results.
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Literature clearly signifies the positive association of diabetes in the incidence of CRC.
Studies have shown poorer outcomes of patients with comorbid diabetes and CRC compared to
CRC in non-diabetic patients, especially in the elderly. Emergency presentation with CRC,
which is an indicator of poor cancer and poor screening practices, is seen in almost a quarter of
the cases that present with CRC. A statistic from a nationally representative database has shown
that diabetic elderly women are less likely to undergo screening for CRC. This is also true for
ethnic minorities and persons of lower socioeconomic status. Poor screening practices, such as
not using the correct method or not screening in a timely fashion can lead to later detection of
cancer and increases the chances of presenting as an emergency case. This is directly associated
with poorer prognosis of the disease and worse outcomes than if the cancer is detected earlier.
Current screening guidelines do not consider diabetics as a special case for earlier screening or
more frequent CRC screening. McBean and Yu have reported that elderly diabetic women are
less likely than elderly non-diabetic women to receive colorectal cancer screening in the 11
SEER areas studied between 1999-2002. (McBean & X, 2007) If a strong association is found
between diabetics with later stage at presentation, and emergency presentation with CRC it may
help strengthen the case for earlier and more frequent screening for CRC in diabetic patients. In
addition it could also be an indicator of the quality of care provided to diabetics by
endocrinologists or physicians, awareness of screening guidelines by healthcare providers and
raise questions at the patient and provider level about the reasons behind such screening
behavior. Survival analysis of diabetics with CRC compared to non-diabetics conducted in a
population which is nationally representative and covers almost 28% of the US population will
also favor the same argument.
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The first aim of this study is to investigate the association between diabetes and stage at
diagnosis of CRC in an elderly population. The association of other covariates such as coronary
atherosclerosis, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF),
age, race, sex, region in the US, patient location, and the frequency of physician office visits with
stage at CRC diagnosis will also be explored.
A second aim is to check the association of diabetes with presenting as an emergency
condition for CRC surgery in the elderly. This will be followed by an investigation of predictors
of emergency condition of CRC surgery in the elderly using large nationally representative
registry data.
Finally, the study aims to explore the effect of diabetes on survival of elderly Medicare
beneficiaries with CRC. This will also explore the association of the covariates including three
most common comorbid conditions (coronary atherosclerosis, chronic obstructive pulmonary
disease heart failure), in addition to diabetes, emergency admission, and treatment variables and
how they affect survival in a CRC patient.
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CHAPTER TWO
DIABETES AND STAGE AT DIAGNOSIS OF COLORECTAL CANCER IN THE MEDICARE
POPULATION
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Introduction
Colorectal cancer (CRC) is the third most common form of cancer after prostate/breast
and lung cancer in the United States. (Gellad, Z.F. 2010; Jemal, A. 2010) In 2011, approximately
141,210 men and women were expected to be diagnosed and approximately 49,380 are expected
to succumb to CRC. (American Cancer Society 2011) The incidence of colorectal adenomas,
which are precursors to the cancer, rises with age and two thirds of all CRC occur in patients
over the age of 65. (Holt, P.R. 2009)
Diabetes is one of three most common comorbid conditions seen in elderly patients with
CRC. (Gross, C.P. 2006) Several prospective and case-control studies have come to the
conclusion of increased risk of CRC in diabetic men and women. (Hu, F.B. 1999; Weiderpass, E.
1997; La Vecchia, C. 1997; Le Marchand, L. 1997) Diabetes and CRC share several risk factors
such as diet low in fiber and high in fat, obesity, and hyperinsulinemia. (Giovannucci, E. 2001)
In addition to the epidemiological evidence of the association of diabetes with CRC, the
hyperinsulinemia hypothesis has suggested that high levels of insulin and glucose might be risk
factors for colorectal carcinogenesis. (McKeown-Eyssen,G. 1994; Giovannucci, E. 2007) This
hypothesis grew from trying to explain the link between colorectal cancer, diets high in fat and
low in vegetables, obesity and from observations that insulin promotes the growth of colon cells
in vitro and colon tumors in vivo. Hyperinsulinemia and hyperglycemia result from the
dysregulation of the interrelationship between insulin secretion and insulin action, which can
also eventually lead to the development of diabetes. The hyperinsulinemia hypothesis has been
furthered by suggesting that because the onset of diabetes is characterized by insulin resistance,
which could lead to hyperinsulinemia, there is an increased level of insulin in diabetes patients as
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well which, as a by-product, leads to a complex chain of events promoting tumor growth in the
colon. (Jin, T. 2008)
Diabetes mellitus also influences mortality of patients with established colorectal cancer.
Clinical trial results have shown that even after adjustment for other predictors of colon cancer,
patients with diabetes and high-risk stage II or stage III colon cancer experienced a significantly
higher rate of overall cancer mortality and cancer recurrence than non-diabetics. (Meyerhardt,
J.A. 2003) A 16 year prospective study showed that after controlling for high body mass,
diabetes was significantly associated with fatal colon cancer in men (RR = 1.20, 95% CI 1.06 1.37) and women (RR = 1.24, 95% CI 1.07 - 1.43).(166 Coughlin,S.S. 2004) In addition, poorly
controlled diabetes independently predicts early onset of CRC, a more advanced stage at the time
of presentation, and a poorer 5-year survival. (Siddiqui, A.A. 2008)
Stage at diagnosis for colorectal cancer directly affects mortality and survival. Chances
for survival are more than 90% for Stage I, 82% for Stage II, 57% for Stage III and drop to 6%
for Stage IV patients. (Gloeckler Ries, L.A. 2003) Although diabetes has been shown to be
associated with the incidence and affects the outcomes of CRC, there are no studies in the US
which have looked at its differential association with stage at diagnosis. Studies in other parts of
the world have mixed results. A study in 2,762 Taiwanese patients of whom 17 % had diabetes,
showed no significant difference in stage at diagnosis, although patients without diabetes were
more frequently diagnosed with stage I (13.7 % vs. 9.0 % in diabetic patients).(Huang, Y.C.
2011) However, the study included both the elderly as well as younger patients. A Dutch study
found that patients with diabetes were more often diagnosed with stage II and less often with
stage I than patients without diabetes, with comparable numbers of stages III and IV. (van de
Poll-Franse, L.V. 2012) A recent cross-sectional analysis of 539 colorectal cancer patients in
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Germany concluded that patients with diabetes were probably diagnosed earlier and therefore
may be at lower risk for advanced stages of colon cancer at diagnosis. (Nagel, J.M. 2012)
The evidence from prospective and retrospective studies, clinical trials, and
pathophysiological reports is substantial to claim that a diabetic patient is at increased risk for the
development of CRC than the average patient. Detection of the cancer at earlier stages greatly
improves the chances of survival. This, therefore, creates a case for detection of colorectal cancer
at an earlier stage especially for diabetic patients.
This study aims to investigate the association between diabetes and stage at diagnosis of
CRC in an elderly population. This study will be the first to report this relationship in a large
nationally representative data. The results of the study will add to existing knowledge about the
association of diabetes and colorectal cancer. The study will also explore the association of other
covariates such as coronary atherosclerosis, chronic obstructive pulmonary disease (COPD),
congestive heart failure (CHF), age, race, sex, region in the US, patient location, and the
frequency of physician office visits with stage at CRC diagnosis which together can inform more
effective CRC screening interventions.

Methods
Newly diagnosed CRC patients were identified in the linked Surveillance, Epidemiology,
and End Results (SEER) – Medicare database from 2003 through 2005. All cases of incident
cancer reported to the SEER registries are cross-matched with a master file of Medicare
enrollment. Previous work has demonstrated excellent agreement among data sources in case
ascertainment. (Potosky, A.L. 1993) Currently, SEER has 17 high quality registries participating
in the program, representing 12 states, and with the Medicare data it effectively represents the
elderly population of the entire United States. (Warren, J.L. 2002)
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Between 2003 and 2005 there were 30,340 cases aged 66 and over with a newly
diagnosed malignant adenocarcinoma of the colon or rectum. Sixty-six was selected as the cutoff to ensure that each person would have at least 12 months of Medicare claims prior to the
diagnosis of CRC. Cases were further included if they had 1) only one primary cancer, 2) were
eligible for both Part A and B benefits for at least 12 months prior to cancer diagnosis, and 3) did
not die in the same month as their cancer diagnosis. Cases with unknown race were eliminated
(N= 38). Cases were further deleted if the source of information was from autopsy or death
certificate only (N= 9). Finally, cases were deleted if their cancer stage was zero or unknown
(N=5,059).
SEER reports disease stage using the third edition of the American Joint Committee on
Cancer (AJCC) definition for the 2003 cases and AJCC Cancer Staging Manual 6th edition
definition for cases diagnoses in 2004 and 2005. Comprehensive stage categories were collapsed
into stages I, II, III and IV. At stage II and over the cancer may expand to other organs and could
also include distant metastases and lymph node involvement, which are strong predictors of
outcome following surgical resection of the cancer. (Gloeckler Ries, L.A. 2003) In addition,
chemotherapy is recommended for treatment only at stage II, III and IV. Therefore, a
dichotomous variable “stage” was created by retaining stage I patients as “early stage” and
collapsing stages II, III and IV into a second category, “late stage”.
Inpatient, outpatient, and physician claims for diabetes for each patient during a period of
12 months before diagnosis of CRC were searched. To maximize specificity, a patient was
identified as diabetic if he or she had at least one inpatient claim or two outpatient claims for
diabetes. (Hebert, P.L. 1999) Since the majority of the patients diagnosed with CRC are over the
age of 65 years they tend to have a greater number of comorbid conditions than younger patients.
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Multimorbidity has a strong impact on the screening, treatment, and survival of patients.
(Yancik, R. 1998; Extermann, M. 2000) Therefore, the association of diabetes with stage at
diagnosis of CRC must be conducted using some of the most common chronic comorbid
conditions seen in these patients as covariates. Comorbid conditions were searched using similar
criteria and the three most common chronic conditions i.e. CHF, coronary atherosclerosis, and
COPD were selected to be included as covariates.
Age was categorized as 66-69 years; 70-74 years; 75-79 years; 80-84 years; and 85 years
and over. Race was categorized as white, black, and other. SEER areas to which the patients
belonged were categorized as west, mid-west, south, and east depending on the region in the US.
Location of the tumor was categorized as proximal (cecum to splenic flexure) and distal
(descending colon to rectum). The categorization was based on the ease of cancer detection
based on the method used for screening or diagnosis. Proximal cancers are identified primarily
through the use of colonoscopy, unlike a sigmoidoscopy which would be unable to reach these
areas. The number of physician office visits 12 months prior to cancer diagnosis was identified
and the continuous variable was transformed into quintiles of office visits with the first quintile
representing the highest number of office visits.
Diabetic patients were matched to non-diabetic patients using a propensity score analysis
in order to control for confounding by factors related to treatment selection. (Rubin, D.B. 1997)
Each Diabetic was matched with two non-diabetics on five characteristics, namely, age, sex,
race, location of the tumor and the SEER region that the patient belonged to. Patients for whom
there was no match were excluded. The final cohort consisted of 16,398 patients.
Patients with cancer detected at an early stage were compared to those detected at late
stage and those with and without diabetes were compared, using Pearson chi-square tests for
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comparisons of proportions. Logistic regression was carried out to explore the association
between diabetes status and early or late stage of CRC diagnosis using the Enter method with
demographic characteristics, patient location, and region as covariates. A separate logistic
regression was run adding number of physician office visits as a covariate. The multivariableadjusted models were constructed using a logit link and a binomial distribution. All statistical
analyses were conducted using IBM SPSS 20.

Results
The mean age of the study cohort was 76.8 years (range 66 to 114) and there were 52.0%
females. Patients were evenly distributed between all stages with 24.8% diagnosed at stage I,
29.9% at stage II, 26.8% at stage III, and 18.6% at stage IV. Tumors were equally divided as
well, with 50.3% located in the proximal area of the colon. There were 5,466 diabetics in the
cohort.
Chi square analyses for stage at diagnosis (Table 1) showed significant differences
between age groups. Patients over the age of 80 were more likely to be diagnosed at later stages
than stage I. Significant relationships were seen between stage at diagnosis with presence of
diabetes and coronary atherosclerosis. Proximal tumors were more likely to be diagnosed at later
stage than distal tumors. Frequency of office visits was also related to stage at diagnosis; patients
with fewer office visits had a greater chance of being diagnosed at late stage. Chi square analyses
for presence of diabetes (Table 2) showed no differences in age, sex and race. There were more
diabetics than non-diabetics that had coronary atherosclerosis (35.5% vs 17.7%), COPD (13.8%
vs 10.4%) and CHF (19.5% vs 8.0%). Diabetics also had a higher frequency of office visits than
non-diabetics.
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Two separate logistic regression models are presented. The first model (Table 3) shows
that diabetes has a significant association with stage at presentation of CRC (OR 0.92; 95% CI
0.85-1.00). Presence of coronary atherosclerosis has lower odds of presenting with later stage of
the cancer (OR 0.85; 95% CI 0.78-0.93). Proximal tumors had 35% greater odds (OR 1.35; 95%
CI 1.26-1.46) of being diagnosed at later stages than tumors located distally. On adding quintile
of office visits to the second model (Table 4) diabetes showed no association with stage at
diagnosis of CRC. Elderly patients over the age of 80 were associated with late stage at
diagnosis. Proximal tumor location continued to remain significantly associated with later stage
at diagnosis (OR 1.40; 95% CI 1.30-1.51). The number of office visits was significantly
associated with stage at diagnosis with decreasing frequency of office visits associated with later
stage at diagnosis.

Discussion
This study aimed to check the association of diabetes with stage at diagnosis of CRC in a
large nationally representative sample of elderly Medicare beneficiaries. Previous studies in the
US and other countries have tested this association in smaller samples with conflicting results. In
this study, diabetes did not show a significant association with stage at diagnosis for CRC.
However, diabetic CRC patients tend to have poorer outcomes than non-diabetic patients, and
therefore it can be argued that the cancer should be detected at an earlier stage than non-diabetics
due to the survival benefit provided at being treated at earlier stages. In addition, if left
uncontrolled, diabetes outcomes in CRC patients are even worse than those with controlled
diabetes. (Siddiqui, A.A. 2008)
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This study also showed that diabetics visited physicians more frequently than nondiabetics and were more likely to have comorbid conditions such as coronary atherosclerosis,
COPD and CHF. This would predispose them to greater recommendations for screening for
various diseases including for CRC and one would therefore expect them to be diagnosed at an
earlier stage than non-diabetics. However, as seen in the regression model, after adjusting for the
number of physician office visits this was not so. A review of barriers and facilitators to
screening for CRC in patients over the age of 65 has reported that although Medicare's coverage
of screening colonoscopy was consistently reported as a facilitator, the most cited barrier related
to healthcare providers was lack of screening recommendation by a physician. (Guessous,I.
2010) Compared to average risk patients, i.e. patients over the age of 50 with no chronic diseases
or history of cancer, diabetics are at an increased-risk for colorectal cancer. A recent study that
examined screening patterns in individuals with varying risk for CRC found that compared to
average risk patients, diabetics were less likely to be recommended by physicians for CRC
screening and were also less likely to be adherent to a recommendation if one was made. (Felsen,
C.B. 2011)
It is important to note that patients over the age of 80 are more likely to be diagnosed at a
later stage than younger patients. This could be due to some guidelines cautioning against use of
invasive methods for screening for patients over the age of 75 due to possible adverse effects of
screening. (Qaseem, A. 2012) All guidelines specifically do not recommend using any invasive
method for screening patients over the age of 85.
The results in this study show that tumors detected within the proximal region in the
colon are found to have progressed much more than the ones located in the distal region at the
time of detection. Distal tumors are easier to detect with less invasive procedures such as
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sigmoidoscopy which cannot look at the large intestine in its entirety and is recommended more
frequently than colonoscopies. Sigmoidoscopes cannot reach the proximal areas of the large
intestine leading to tumors in those areas to go undetected. (Schoen, R.E. 2012) In addition,
proximal tumor location even after controlling for stage has also been significantly associated
with poorer mortality and survival as compared to distally located colon cancers. (Wray, C.M.
2009) This study points to a greater need for further investigation in the differential prevalence
of colorectal tumor location in the elderly. Future studies should also investigate use of screening
methods and their association with tumor location in the colorectal region and how it affects
outcomes such as survival and mortality.
Although this study has several strengths including stringent inclusion and exclusion
criteria, a large nationally representative sample, and registry level data, it must be seen in light
of its limitations. We used previously employed algorithms to identify diabetic patients,
however, we were unable to identify the duration of diabetes as well as clinical values such as
HbA1C which may have significantly affected the stage at which patients were diagnosed with
CRC. Siddiqui et al have reported that uncontrolled diabetes and therefore increased HbA1C
levels leads to diagnosis of CRC at later stages than diabetes that is under control. (Siddiqui,
A.A. 2008) Future studies in the elderly must take into consideration clinical values and duration
of diabetes. Timely screening plays a crucial role in detecting the cancer at earlier stages and the
data did not allow us to check for frequency of screening. This is especially true for
sigmoidoscopy and colonoscopy procedures which are recommended to be performed at five
year and ten year intervals, respectively. In addition, SEER–Medicare data do not include other
important measures of health status, such as body mass index, diet, functional disabilities or
geriatric syndromes.
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In conclusion, this study shows that the association between diabetes and stage at
diagnosis of colorectal cancer in those 65 years and older, although not statistically significant,
must be further explored. Tumor location in diabetics must be studied further with a focus on
detecting proximal tumors at earlier stages. Dialogue between the physician and diabetic patient
should be encouraged to discuss screening for CRC. Diabetic patients should be screened for the
cancer either more frequently or begin at an age earlier than the average risk patient in order to
detect the cancer at early.
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Table 1: Characteristics of patients by Stage at Diagnosis of CRC
Patient Characteristic
Stage at Diagnosis
p
Early
Late
N %
N %
0.004
Age Group
2,085 16.9%
66-69
730 18.0%
2,823 22.9%
70-74
962 23.7%
26.4%
3,124 25.3%
75-79
1,070
2,452 19.9%
80-84
776 19.1%
1,855 15.0%
85 and over
521 12.8%
Sex
Male
Female
Race
White
Black
Other
Diabetes
No
Yes
Atherosclerosis
No
Yes
COPD
No
Yes
CHF
No
Yes
Region
West
Midwest
South
East
Tumor Site
Distal Tumor
Proximal Tumor
Quintile Office Visits
First
Second
Third
Fourth
Fifth

0.295
1,977
2,082

48.7%
51.3%

5,893
6,446

47.8%
52.2%

3,246
416
397

80.0%
10.2%
9.8%

9,888
1,322
1,129

80.1%
10.7%
9.1%

2,629
1,430

64.8%
35.2%

8,303
4,036

67.3%
32.7%

3,007
1,052

74.1%
25.9%

9,509
2,830

77.1%
22.9%

3,558
501

87.7%
12.3%

10,953
1,386

88.8%
11.2%

3,553
506

87.5%
12.5%

10,897
1,442

80.5%
11.7%

1,525
624
798
1,112

37.6%
15.4%
19.7%
27.4%

4,677
1,881
2,336
3,445

37.9%
15.2%
18.9%
27.9%

2,249
1,810

55.4%
44.6%

5,895
6,444

47.8%
52.2%

1,025
919
833
749
533

25.3%
22.6%
20.5%
18.5%
13.1%

2,556
2,573
2,430
2,316
2,464

20.7%
20.9%
19.7%
18.8%
20.0%

0.379

0.003

0.000

0.055

0.183

0.736

0.000

0.000

Continued
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Table 1: Characteristics of patients by Stage at Diagnosis of CRC
Patient Characteristic
Stage at Diagnosis
p
Early
Late
0.141
Patient Location
Big Metro
2,225 54.8%
6,993 56.7%
Metro
1,143 28.2%
3,390 27.5%
Urban
248 6.1%
708 5.7%
Less Urban
369 9.1%
994 8.1%
Rural
74 1.8%
254 2.1%
TOTAL

4,059

12,399
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Table 2: Characteristics of patients by Diabetes Status
Patient Characteristic
Presence of Diabetes
No
Yes
N %
N
Age Group
66-69
70-74
75-79
80-84
85 and over
Sex
Male
Female
Race
White
Black
Other
Stage
Early
Late
Coronary Athero
No
Yes
COPD
No
Yes
CHF
No
Yes
Region
West
Midwest
South
East
Tumor Site
Distal Tumor
Proximal Tumor
Quintile Office Visits
First
Second
Third
Fourth
Fifth

p
%
0.150

1,919
2,528
2,738
2,165
1,582

17.6%
23.1%
25.0%
19.8%
14.5%

896
1,257
1,456
1,063
794

16.4%
23.0%
26.6%
19.4%
14.5%

5,259
5,673

48.1%
51.9%

2,611
2,855

47.8%
52.2%

8,788
1,132
1,012

80.4%
10.4%
9.3%

4,346
606
514

79.5%
11.1%
9.4%

2,629
8,303

24.0%
76.0%

1,430
4,036

26.2%
73.8%

8,992
1,940

82.3%
17.7%

3,524
1,942

64.5%
35.5%

9,797
1,135

89.6%
10.4%

4,714
752

86.2%
13.8%

10,052
880

92.0%
8.0%

4,398
1,068

80.5%
19.5%

4,138
1,637
2,111
3,046

37.9%
15.0%
19.3%
27.9%

2,064
868
1,023
1,511

37.8%
15.9%
18.7%
27.6%

5,437
5,495

49.7%
50.3%

2,707
2,759

49.5%
50.5%

1,714
2,027
2,133
2,283
2,775

15.7%
18.5%
19.5%
20.9%
25.4%

1,867
1,465
1,130
782
222

34.2%
26.8%
20.7%
14.3%
4.1%

0.683

0.320

0.003

0.000

0.000

0.000

0.440

0.799

0.000

Continued
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Table 2: Characteristics of patients by Diabetes Status
Patient Characteristic
Presence of Diabetes
No
Yes
N %
N

%

Patient Location
Big Metro
Metro
Urban
Less Urban
Rural

56.3%
28.0%
5.8%
8.0%
1.9%

TOTAL

p

0.814
6,143
3,001
641
923
224

56.2%
27.5%
5.9%
8.4%
2.0%

10,932

100.0%

3,075
1,532
315
440
104
54,66
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Table 3: Association of diabetes with stage at diagnosis of Colorectal Cancer
95% C.I.for Odds
Patient Characteristic
Diabetes
Comorbidities
Coronary Athero

p
.039

Sig
***

Odds
0.92

Lower
0.85

Upper
1.00

.000

***

0.85

0.78

0.93

COPD

.200

0.93

0.83

1.04

CHF

.957

1.00

0.89

1.12

66-69

.019

70-74

.658

1.03

0.92

1.15

75-79

.905

1.01

0.90

1.12

80-84

.158

1.09

0.97

1.23

85 and over

.004

1.21

1.06

1.39

Female

.518

0.98

0.91

1.05

White

.395

Black

.516

1.04

0.92

1.17

Other

.254

0.93

0.82

1.06

Proximal

.000

***

1.35

1.26

1.46

WEST

.941

Referent

MIDWEST

.653

0.97

0.87

1.09

SOUTH

.561

0.97

0.87

1.08

EAST

.755

0.99

0.90

1.08

Big Metro

.153

Metro

.148

0.94

0.86

1.02

Urban

.264

0.92

0.78

1.07

Less Urban

.040

0.86

0.75

0.99

Rural

.524

1.09

0.83

1.43

Constant

.000

2.64

Referent

Age Group

***

Sex
Referent

Race

Tumor Location
Region in the US

Referent

Patient Location

Coronary Athero = Coronary Atherosclerosis; COPD = Chronic Obstructive Pulmonary Disorder; CHF =
Congestive Heart Failure
Referent group for Diabetes, Coronary Atherosclerosis, COPD and CHF are No Diabetes, No Coronary
Atherosclerosis, No COPD and No CHF respectively
Referent group for female is male
Referent group for proximal tumor location is distal tumor location
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Table 4: Association of diabetes with stage at diagnosis of Colorectal Cancer
95% C.I.for Odds
Patient Characteristic
Diabetes

.309

p

Sig

Odds
1.04

Lower
0.96

Upper
1.13

Coronary Athero

.370

0.96

0.87

1.05

COPD

.750

1.02

0.91

1.14

CHF

.214

1.08

0.96

1.22

66-69

.000

70-74

.357

1.05

0.94

1.18

75-79

.258

1.07

0.95

1.19

80-84

.009

***

1.18

1.04

1.33

85 and over

.000

***

1.32

1.15

1.50

Female

.483

1.03

0.95

1.11

White

.342

Black

.988

1.00

0.89

1.13

Other

.145

0.91

0.80

1.03

Proximal

.000

***

1.40

1.30

1.51

WEST

.820

Referent

MIDWEST

.503

0.96

0.86

1.08

SOUTH

.373

0.95

0.85

1.06

EAST

.730

0.98

0.90

1.08

Big Metro

.081

Metro

.090

0.93

0.86

1.01

Urban

.192

0.90

0.77

1.05

Less Urban

.020

0.85

0.74

0.97

Rural

.623

1.07

0.82

1.41

Comorbidities

Referent

Age Group

Sex
Referent

Race

Tumor Location
Region in the US

Referent

Patient Location

Continued
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Table 4: Association of diabetes with stage at diagnosis of Colorectal Cancer
95% C.I.for Odds
Patient Characteristic
Quintile of Office
Visits

First Quintile

.000

p

Sig
Referent

Second

.007

***

1.16

1.04

1.29

Third

.000

***

1.25

1.12

1.40

Fourth

.000

***

1.37

1.21

1.54

Fifth

.000

***

2.13

1.86

2.44

Constant

.000

Odds

Lower

Upper

1.671

Coronary Athero = Coronary Atherosclerosis; COPD = Chronic Obstructive Pulmonary Disorder; CHF =
Congestive Heart Failure
Referent group for Diabetes, Coronary Atherosclerosis, COPD and CHF are No Diabetes, No Coronary
Atherosclerosis, No COPD and No CHF respectively
Referent group for female is male
Referent group for proximal tumor location is distal tumor location
First quintile in Office Visits represents highest number of office visits and fifth represents the lowest
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CHAPTER THREE

ASSOCIATION OF DIABETES AND PREDICTORS OF EMERGENCY CONDITION FOR COLORECTAL
CANCER SURGERY IN THE MEDICARE POPULATION
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Introduction
Colorectal cancer (CRC) is ranked third in incidence and mortality of all cancers in both
men and women. (American Cancer Society, 2011; Gellad & Provenzale, 2010; Jemal, Siegel,
Xu, & Ward, 2010) In 2011 approximately 141,210 men and women were expected to be
diagnosed and approximately 49,380 are expected to succumb to CRC. (American Cancer
Society, 2011) Screening for CRC can identify polyps or abnormal growths before they turn
cancerous. Disparities in screening, treatment, and survival persist even with incidence and
mortality from CRC decreasing significantly due to increasing screening rates. (Gellad &
Provenzale, 2010) (Hao, Jemal, Zhang, & Ward, 2009; Hoff & Dominitz, 2010; Meissner, Breen,
Klabunde, & Vernon, 2006)
The incidence of CRC is uncommon under the age of 50 years where it is predominantly
in tumors induced by heredity and with a family history. However, between the ages of 50 and
85 years the incidence increases exponentially, with two-thirds of all cancers occurring in
patients over the age of 65. (Everhart & Ruhl, 2009; Ries et al., 2007; Rim, Seeff, Ahmed, King,
& Coughlin, 2009)
Comorbidity, or illnesses other than the primary illness under treatment, is more common
in the elderly. (Shack, Rachet, Williams, Northover, & Coleman, 2010) Older individuals also
often present with chronic conditions that complicate the diagnostic and clinical management of
CRC which leads to poorer prognosis and outcomes of the cancer. (Satariano & Silliman, 2003;
Yancik et al., 1998) In their review of population-based studies including CRC patients 65 years
and older, Faivre and colleagues reported that comorbidity was shown to be an independent
prognostic factor. (Faivre, Lemmens, Quipourt, & Bouvier, 2007). The study added that
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comorbidities such as previous malignancy, cardiovascular diseases, chronic obstructive
pulmonary disease (COPD), hypertension and diabetes decreased 5-year survival compared to
patients with CRC with no comorbidity. The three most common comorbid conditions seen in
elderly patients with CRC are congestive heart failure, chronic obstructive pulmonary disease
and diabetes mellitus. (Gross et al., 2006) There is a lack of studies exploring the association of
chronic comorbid conditions with the diagnosis of CRC.
Of all comorbid conditions, the association of diabetes with CRC has been studied most
extensively and has been established with prospective, case-control and retrospective studies
providing overwhelming evidence. (Elwing, Gao, Davidson, & Early, 2006; Hu et al., 1999; Hu
et al., 1999; Limburg et al., 2005; Limburg et al., 2006; Vinikoor et al., 2009; Will, Galuska,
Vinicor, & Calle, 1998) Unlike with other diseases, in addition to the epidemiological evidence,
pathophysiological evidence has also contributed in understanding the link between diabetes and
CRC. (Giovannucci, 2001; Jin, 2008; McKeown-Eyssen, 1994) Diabetes also affects the
outcomes of CRC as reported by several investigators. Reports from around the world have
concluded that diabetic CRC patients have worse outcomes than non-diabetic patients which may
either be a results of less aggressive treatment of the cancer or poorly controlled diabetes.
(Coughlin, Calle, Teras, Petrelli, & Thun, 2004; Gross et al., 2006; Lemmens et al., 2005;
Meyerhardt et al., 2003; Siddiqui et al., 2008) Surgical resection is the only curative treatment of
colorectal cancer, performed as an open, surgical procedure requiring hospitalization. (Mitry,
Barthod, Penna, & Nordlinger, 2002; Redaelli, Cranor, Okano, & Reese, 2003) Emergency
presentation with CRC, which is an indicator of poor prognosis, and poor screening practices, is
seen in almost a quarter of the cases that present with CRC. (Kim et al., 2007; Polednak, 2000;
Smothers et al., 2003) A nationally representative database has shown that diabetic elderly
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women are less likely to undergo screening for CRC. (Limburg et al., 2005) This is also true for
ethnic minorities and persons of lower socioeconomic status. (Hood et al., 2010; Rich, Kuyateh,
Dwyer, Groves, & Steinberger, 2011) Poor screening practices, such as not using the correct
method or not screening in a timely fashion can lead to later detection of cancer and increases the
chances of presenting as an emergency case. This is directly associated with poorer prognosis of
the disease and worse outcomes than if the cancer is detected earlier.
Potentially fatal complications of colorectal cancer include bowel perforation, peritonitis,
and obstruction. These complications are considered surgical emergencies and are the initial
presentation of colorectal cancer in an estimated 15% to 30% of patients with colorectal cancer.
(Diggs, Xu, Diaz, Cooper, & Koroukian, 2007)In addition, patients with emergency room
presentation of CRC have increased 30-day mortality and decreased 5-year survival compared to
those scheduled for elective surgery. (Mitchell, Inglis, Murdoch, & Porter, 2007)
Predictors of presenting as an emergency have been examined by Polednak who used the
Connecticut tumor registry to estimate the frequency and characteristics of first inpatient hospital
admission through an emergency department (ED) among more than 11,000 patients. (Polednak,
2000). He found that age greater than 75 years, black race, and proximal cancer were significant
predictors of admission through the ED. A study by Diggs and colleagues used hospital
discharge data to examine the association of demographic characteristics, insurance status and
number of comorbidities with emergency condition for CRC resection surgery. They found that
older age, being male, black and being uninsured increased the likelihood of presenting
emergently. (Diggs et al., 2007) However, the study by Polednak did not examine any comorbid
conditions such as diabetes and was limited to patients in Connecticut, and Diggs’ study is
limited by the fact that they used discharge data not incident data, used elderly as well as
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younger patients, was lacking in information on stage of cancer, and had no information on
specific comorbid conditions. No other study in the US has attempted to study the predictors of
emergency condition for CRC surgery.
As evidence shows diabetic patients are at an increased risk for the development of CRC
and are predisposed to worse outcomes than a non-diabetic CRC patient. A diabetic patient
presenting as an emergency condition for CRC surgery could compound the prognosis, with a
potential for poorer chances of survival. Therefore, it is imperative to check the association of
diabetes and other covariates with presenting emergently for CRC surgery. This study is the
first to comprehensively study the predictors of emergency condition for CRC resection surgery
in newly diagnosed CRC patients over 65 years of age. This study is also the first to report the
association of diabetes and other frequently seen comorbid conditions in CRC patients over 65
years of age with emergency condition for surgical resection. The aim of the study is to check the
association of diabetes with presenting as an emergency condition for CRC surgery in those over
65 years of age. A second aim is to indentify predictors of emergency condition of CRC surgery
in those over 65 years of age using a large nationally representative registry data.

Methods
Data
The study was a retrospective cross sectional analysis of data from the Surveillance,
Epidemiology and End Results-Medicare (SEER-Medicare) files for the years 2003 to 2005. The
SEER-Medicare data reflect the linkage of two large population-based sources of data that
provide detailed information about Medicare beneficiaries with cancer. The data come from the
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SEER program of cancer registries that collect clinical, demographic and cause of death
information for persons with cancer and the Medicare claims for covered health care services
from the time of a person's Medicare eligibility until death. The linkage of these two data sources
results in a unique population-based source of information that can be used for an array of
epidemiological and health services research. Previous work has demonstrated excellent
agreement among data sources in case ascertainment. (Potosky, Riley, Lubitz, Mentnech, &
Kessler, 1993) Currently, SEER has 17 high quality registries participating in the program,
representing 12 states, and with the Medicare data it effectively represents the elderly population
of the entire United States. (Warren, Klabunde, Schrag, Bach, & Riley, 2002)
Cohort
Between 2003 and 2005 there were 30,340 cases aged 66 and over with a newly
diagnosed malignant adenocarcinoma of the colon or rectum. Sixty-six was selected as the cutoff to ensure that each person would have at least 12 months of Medicare claims prior to the
diagnosis of CRC. Cases were further included if they had 1) only one primary cancer, 2) were
eligible for both Part A and B benefits for at least 12 months prior to cancer diagnosis, and 3) did
not die in the same month as their cancer diagnosis. Cases with unknown race were eliminated
(N= 38). Cases were further deleted if the source of information was from autopsy or death
certificate only (N= 9). Finally, cases were deleted if their cancer stage was zero or unknown
(N=5,059). Cases were also excluded if they did not undergo any type of CRC resection surgery
(N = 4,152).
The next step was to identify patients who underwent CRC resection procedures in the
colon and rectum. These patients were identified using the International Classification of
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Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) procedure codes for colon resection
(codes 45.7x and 45.8), rectal resection (codes 48.4x, 48.5, 48.6x), and other operations on the
intestine including colostomy and ileostomy (codes 46.1-2). (Diggs et al., 2007; Etzioni, Beart,
Madoff, & Ault, 2009; Hayanga et al., 2010) Patients were identified as being an emergency case
for CRC surgery if they also had diagnosis codes of bowel perforation, peritonitis, or obstruction.
The ICD-9-CM diagnosis codes used to determine which patients met these criteria included
other specified intestinal obstruction (code 560.8), unspecified intestinal obstruction (code
560.9), peritonitis in infectious diseases (code 567.0), other suppurative peritonitis (code 567.2),
other specified peritonitis (code 567.8), unspecified peritonitis (code 567.9), and perforation of
the intestine (code 569.83). The final cohort for this study consisted of 21,082 patients.
Construction of Variables
Inpatient, outpatient, and physician claims for diabetes for each patient during a period of
12 months before diagnosis of CRC were searched. To maximize specificity, a patient was
identified as diabetic if he or she had at least one inpatient claim or two outpatient claims for
diabetes. (Hebert et al., 1999) Since majority of the patients diagnosed with CRC are over the
age of 65 years they tend to have a greater number of comorbid conditions than younger patients.
Multimorbidity has a strong impact on the screening, treatment, and survival of patients.
(Extermann, 2000; Yancik et al., 1998) Therefore, the association of diabetes with emergency
surgery for CRC must be conducted using some of the most common chronic comorbid
conditions seen in these patients as covariates. Comorbid conditions were searched using similar
criteria and the three most common chronic conditions i.e. congestive heart failure (CHF),
coronary atherosclerosis, and COPD were selected to be included as covariates.
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SEER reports disease stage using the third edition of the American Joint Committee on
Cancer (AJCC) definition for the 2003 cases and AJCC Cancer Staging Manual 6th edition
definition for cases diagnoses in 2004 and 2005. Comprehensive stage categories were collapsed
into stages I, II, III and IV. Stage at diagnosis for colorectal cancer directly affects mortality and
survival. Chances for survival are more than 90% for Stage I, 82% for Stage II, 57% for Stage III
and drop to 6% for Stage IV patients.{{189 Gloeckler Ries,L.A. 2003}}Due to these differential
survival rates between the stages, patients were categorized as being “Early Stage” (Stage I and
II) or “Late Stage” (Stages III and IV) patients.
Age was categorized as 66-69 years, 70-74 years, 75-79 years, 80-84 years, and 85 years
and over. Race was categorized as white, black, and other. SEER areas to which the patients
belonged were categorized as west, mid-west, south, and east depending on the region in the US.
Location of the tumor was categorized as proximal (cecum to splenic flexure) and distal
(descending colon to rectum). The categorization was based on the ease of cancer detection
based on the method used for screening or diagnosis. Proximal cancers are identified primarily
through the use of colonoscopy, unlike a sigmoidoscopy which would be unable to reach these
areas. The number of physician office visits 12 months prior to cancer diagnosis was identified
and the continuous variable was transformed into quintiles of office visits with the first quintile
representing the highest number of office visits.
Analyses
Patients undergoing emergency versus elective surgery for CRC were initially compared
using descriptive statistics against the independent variables using Pearson chi-square tests for
comparison of proportions. Similarly patients with and without diabetes were also compared
using the bivariate statistic.
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The association of diabetes with emergency surgery for CRC was analyzed by employing
multivariate logistic regression. After check the goodness-of-fit using the Hosmer-Lemeshow
test statistic, the final model using the Enter method was analyzed. The predictors of emergency
surgery for colorectal cancer were tested in the same model. The multivariable-adjusted models
were constructed using a logit link and a binomial distribution. All statistical analyses were
conducted using IBM SPSS 20.
Results
In a sample of 21,082 patients, the mean age was 77.4 years (range 66 to 106 years).
There were 56.5% female patients and the sample was largely white (85.3%). There were 22.2%
diabetic patients, 22.0% of the sample had coronary atherosclerosis, and the proportion of
patients that had COPD and CHF were 10.8% and 10.6%, respectively. The sample had a
proportion of 23.1% patients that were diagnosed at Stage I, 33.8% at stage II, 29.4% at stage III
and 13.7% at stage IV. Tumor location was evenly distributed among the patients with 54.1%
patients having a proximal tumor. The number of patients that were classified as having an
emergency condition for CRC surgery was 2,242 or 10.4% of the sample.
The bivariate analysis for emergency versus non-emergency patients showed that older
patients were more likely to be a candidate for emergency surgery for CRC (Table 1). This was
especially seen in patients over the age of 80 years. Patients classified as emergency candidates
were more likely to be diagnosed at later stages than earlier stages and there was a significantly
greater likelihood of a patient having a distal tumor than a proximal tumor. The results also
showed that patients with lower frequency of office visits were more likely to be classified as an
emergency rather than non-emergency case. There was also a significant difference between
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diabetics and non-diabetics in their distribution between emergency and non-emergency
condition for CRC surgery.
The distribution of patients between diabetics and non-diabetics by age showed that with
increasing age in the elderly, the proportion of diabetics increased and peaked between the age
range 75-79 years and then decreased thereafter (Table 2). There were more diabetic women in
the sample than men, and there were more diabetic patients of black and other races than white
patients. Diabetic patients represented the most frequently visited category in terms of quintiles
of physician office visits, and the eastern region of the US had a greater proportion of diabetics
than the rest of the country.
Logistic regression results (Table 3) indicated that although the odds of a diabetic patient
being an emergency patient were lower than a non-diabetic, this was not statistically significant
(OR 0.89; 95% CI 0.79-1.01). Coronary atherosclerosis patients had lower odds of being
classified as emergency (OR 0.82; 95% CI 0.72-0.93) whereas those with COPD had increased
odds (OR 1.28; 95% CI 1.11-1.49). Patients with late stage at diagnosis had a 75% greater
chance of being emergency patients than stage I patients (OR 1.75; 95% CI 1.60-1.91). Proximal
tumor location lent itself to being negatively associated with being classified as an emergency
case for CRC surgery. Compared to whites, blacks were more prone to being emergency cases
(OR 1.27; 95% CI 1.08-1.49). The regression also showed that compared to the highest quintile
of office visits, patients belonging to the lowest quintile had greater odds of being an emergency
patient (OR 1.48; 95% CI 1.26-1.74).
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Discussion
This study is the first to report the association of diabetes with emergency surgery for
CRC, and explore the predictors of emergency colorectal cancer surgery in a large nationally
representative sample. The study showed that although the odds of being an emergency patient
for CRC surgery were lower for diabetic patients, this association was not significant. However,
this result must be interpreted in light of the fact that diabetic patients belonged to the highest
quintile in terms of physician office visits. Previous reports of a Medicare population have
mentioned that having any physician office visit, increased number of office visits, and visits
with primary care physicians are associated with increased CRC test use. (Schenck et al., 2011)
Klabunde and colleagues have reported that having a chronic condition such as diabetes is a
predictor of receiving a physician recommendation for CRC screening. (Klabunde, Schenck, &
Davis, 2006) Increased number of physician office visits increases the chances of being
recommended for a screening test; and clinician recommendation for a screening test has been
proven to be a strong predictor in the elderly as well as young patients to adhere to screening
practices for CRC. (Felsen, Piasecki, Ferrante, Ohman-Strickland, & Crabtree, 2011; Gilbert &
Kanarek, 2005)
This study also showed that compared to Whites, Black patients were more likely to be
classified as an emergency condition for CRC surgery. It has been reported that Blacks,
Hispanics, and American Indians/Alaska Natives were less likely to report receiving
a recommendation for sigmoidoscopy compared to Whites. (Coughlin & Thompson, 2005)
Whites are also more likely than Blacks to report ever receiving a provider recommendation for a
colonoscopy. Although the proportion of patients receiving recommendations for
colonoscopy/sigmoidoscopy increased over time, the gap between races remained unchanged,
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even after controlling for insurance status. (Rich et al., 2011) A study by Hood and colleagues
has reported that although over 80% of their sample of 439 blacks was covered by insurance, less
than 50% reported receiving a recommendation to screen for CRC. (Hood et al., 2010) This calls
for immediate intervention and strategies for improving physician recommendation in this
subgroup of the population.
This study also showed that the odds of being an emergency case for CRC surgery were
higher for patients over the age of 80 years. However, this may be due to several guidelines
cautioning against use of invasive methods for screening of patients over the age of 75 because
of possible adverse effects of screening. Thus it is possible that the cancer does not get detected
in early stages in this age group. (Qaseem et al., 2012) All the guidelines specifically do not
recommend using any invasive method for screening patients over the age of 85.
The results of this study also showed that having a proximal tumor decreased the odds of
being an emergency case for CRC surgery. This study is the first to report an association
between tumor location and emergency condition for surgery for CRC. However, it has been
reported that screening for CRC does not have a survival benefit in patients with proximal
cancers despite recent epidemiologic studies suggesting an overall shift to more proximal sites of
colon cancer distribution. (Wong, 2010) Proximal cancer tumor biology also makes it hard for
them to be detected. There are underlying differences in the biology of proximal and distal CRC
neoplasia that may contribute to the variable effectiveness of colonoscopy. (Baxter, Warren,
Barrett, Stukel, & Doria-Rose, 2012) This may mean that proximal tumors were possibly
underrepresented in the sample in this study. Further investigation into the association between
tumor location and emergency condition for CRC surgery is warranted.
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Strengths of this study include the use of population based data from a cancer registry
that is globally recognized as an authoritative source of information on cancer incidence in the
United States. Detailed demographic and cancer data on stage and tumor location allowed for
multivariable regression analysis of emergency condition for CRC surgery variations in patients
with and without diabetes that adjusted for several potential major confounders.
Despite its strengths the limitations of the study must be acknowledged. Previously
employed algorithms were used to identify diabetic patients. However, the study was unable to
identify the duration of diabetes as well as clinical values such as HbA1C which may have
significantly affected the stage at which patients were diagnosed with CRC. Siddiqui et al have
reported that uncontrolled diabetes and therefore increased HbA1C levels leads to diagnosis of
CRC at later stages than diabetes that is under control. (Siddiqui et al., 2008) Future studies in
the elderly must take into consideration clinical values and duration of diabetes. The study
population was limited to those undergoing resection procedures, and many patients presenting
in emergency settings with CRC but who did not undergo surgery such as severe cases in which
surgery would have been unsuccessful or the patient refused treatment, may not have been
represented.
Emergency surgery for CRC can have a significant impact on the progression of the
disease. Predictors of emergency surgery such as race, and tumor location, must be explored
further to avoid the burden associated with the condition. Stage at diagnosis is significantly
associated with emergency surgery, which can be avoided by regular CRC screening.
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Table 1: Characteristics of CRC surgery patients by Emergency status
Patient Characteristic
Emergency
No
Yes
N %
N %
Diabetes
No
14,629 77.4%
1,782 81.4%
Yes
4,263 22.6%
408 18.6%
Coronary Athero
No
14,655 77.6%
1,797 82.1%
Yes
4,237 22.4%
393 17.9%
COPD
No
16,864 89.3%
1,937 88.4%
10.7%
Yes
2,028
253 11.6%
CHF
No
16,868 89.3%
1,972 90.0%
Yes
2,024 10.7%
218 10.0%
Stage
Early
11,041 58.4%
972 44.4%
41.6%
Late
7,851
1,218 55.6%
Age Group
66-69
3,044 16.1%
339 15.5%
70-74
4,098 21.7%
455 20.8%
75-79
4,665 24.7%
435 19.9%
20.9%
80-84
3,957
488 22.3%
16.6%
85 and over
3,128
473 21.6%
Sex
Male
8,223 43.5%
952 43.5%
Female
10,669 56.5%
1,238 56.5%
Race
White
16,157 85.5%
1,827 83.4%
Black
1,447 7.7%
203 9.3%
Other
1,288 6.8%
160 7.3%
Tumor Site
Distal
8,547 45.2%
1,129 51.6%
54.8%
Proximal
10,345
1,061 48.4%
Quintile of office visits
First
3,933 20.8%
402 18.4%
Second
4,100 21.7%
408 18.6%
Third
3,898 20.6%
418 19.1%
19.9%
Fourth
3,761
444 20.3%
16.9%
Fifth
3,200
518 23.7%
Region in the US
WEST
7,584 40.1%
933 42.6%
MIDWEST
3,051 16.1%
281 12.8%
19.1%
SOUTH
3,614
370 16.9%
24.6%
EAST
4,643
606 27.7%

Continued
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p

0.000

0.000

0.243

0.275

0.000

0.000

0.960

0.017

0.000

0.000

0.000
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Table 1: Characteristics of CRC surgery patients by Emergency status
Patient Characteristic
Emergency
No
Yes
Patient Location
Big Metro
10,305 54.5%
1,284 58.6%
Metro
5,391 28.5%
586 26.8%
Urban
1,154 6.1%
123 5.6%
Less Urban
1,659 8.8%
159 7.3%
Rural
383 2.0%
38 1.7%
TOTAL
18,892 100.0% 2,190 100.0%
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Table 2: Characteristics of CRC surgery patients by Diabetes Status
Patient Characteristic

Diabetes

p

No
N

Yes

%

N

%
0.000

Emergency
No

14,629

77.4%

4,263

81.4%

Yes

1,782

22.6%

408

18.6%
0.000

Coronary Athero
No

13,430

81.8%

3,022

64.7%

Yes

2,981

18.2%

1,649

35.3%
0.000

COPD
No

14,748

89.9%

4,053

86.8%

Yes

1,663

10.1%

618

13.2%
0.000

CHF
No

15,038

91.6%

3,802

81.4%

Yes

1,373

8.4%

869

18.6%

Stage
Early

3,761

22.9%

1,117

23.9%

Late

12,650

77.1%

3,554

76.1%

0.154

0.000

Age Group
66-69

2,601

15.8%

782

16.7%

70-74

3,464

21.1%

1,089

23.3%

75-79

3,828

23.3%

1,272

27.2%

80-84

3,544

21.6%

901

19.3%

85 and over

2,974

18.1%

627

13.4%
0.000

Sex
Male

6,979

42.5%

2,196

47.0%

Female

9,432

57.5%

2,475

53.0%

Race
White

14,257

86.9%

3,727

79.8%

Black

1,143

7.0%

507

10.9%

Other

1,011

6.2%

437

9.4%

Tumor Site
Distal

7,535

45.9%

2,141

45.8%

Proximal

8,876

54.1%

2,530

54.2%

0.000

0.924

0.000

Quintile of office visits
First

2,751

16.8%

1,584

33.9%

Second

3,248

19.8%

1,260

27.0%

Third

3,320

20.2%

996

21.3%

Fourth

3,541

21.6%

664

14.2%

Fifth

3,551

21.6%

167

3.6%

Continued
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Table 2: Characteristics of CRC surgery patients by Diabetes Status
Patient Characteristic

Diabetes
No

p
Yes
0.000

Region in the US
WEST

6,757

41.2%

1,760

37.7%

MIDWEST

2,594

15.8%

738

15.8%

SOUTH

3,115

19.0%

869

18.6%

EAST

3,945

24.0%

1,304

27.9%

Patient Location
Big Metro

8,963

54.6%

2,626

56.2%

Metro

4,649

28.3%

1,328

28.4%

Urban

1,011

6.2%

266

5.7%

Less Urban

1,454

8.9%

364

7.8%

334

2.0%

87

1.9%

16,411

100.0%

4,671

100.0%

Rural
TOTAL

0.079
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Table 3: Association of Diabetes and Covariates with Emergency Condition for Surgery
95% C.I.for Odds
Patient Characteristic
Diabetes

p
.063

Odds
0.89

Lower
0.79

Upper
1.01

Atherosclerosis

.003

***

0.82

0.72

0.93

COPD

.001

CHF

.927

***

1.28

1.11

1.49

1.01

0.85

1.19

Stage

Late

.000

***

1.75

1.60

1.91

Region in the US

WEST

.000

Referent

MIDWEST

.000

SOUTH

.006

***

0.75

0.65

0.87

***

0.82

0.72

0.95

EAST

.473

1.04

0.93

1.17

Location of tumor

Proximal

.000

***

0.78

0.71

0.85

Age Group

66-69

.000

Referent

70-74

.515

1.05

0.91

1.22

75-79

.282

0.92

0.79

1.07

80-84

.002

***

1.28

1.10

1.48

85 and over

.000

***

1.62

1.39

1.89

Sex

FEMALE

.994

1.00

0.91

1.10

Race

White

.016

Referent

Black

.004

***

1.27

1.08

1.49

Other

.879

1.01

0.85

1.21

Big Metro

.263

Referent

Metro

.047

***

0.90

0.81

1.00

Urban

.333

0.91

0.74

1.11

Less Urban

.150

0.87

0.73

1.05

Rural

.664

0.93

0.65

1.31

First

.000

Second

.571

0.96

0.83

1.11

Third

.807

1.02

0.88

1.19

Fourth

.130

1.13

0.97

1.32

Fifth

.000

1.48

1.26

1.74

Comorbidities

Patient Location

Quintile of Office
Visits

Sig

Referent

***

*** Significant at the p = 0.05 level
Coronary Athero = Coronary Atherosclerosis; COPD = Chronic Obstructive Pulmonary Disorder; CHF =
Congestive Heart Failure
Referent group for Diabetes, Coronary Atherosclerosis, COPD and CHF are No Diabetes, No Coronary
Atherosclerosis, No COPD and No CHF respectively
Referent group for female is male
Referent group for proximal tumor location is distal tumor location
First quintile in Office Visits represents highest number of office visits and fifth represents the lowest
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CHAPTER FOUR

IMPACT OF PRE-EXISTING DIABETES ON COLORECTAL CANCER MORTALITY
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Introduction
Mortality from colorectal cancer (CRC) has been decreasing in the past 20 years due to
advances in both early detection and treatment. (American Cancer Society, 2011) This decline in
cancer mortality for the US population was statistically significant in 1994 through 1998 with
rates leveling off from 1998-2000, which may have been due to a change in the classification of
deaths due to cancer. (Ries et al., 2007) A significant part of the overall decline in cancer
mortality, and the resultant increase in survival, appears to be due to the success of various
initiatives by the National Cancer Institute. Despite the significant survival benefits seen in CRC
due to increasing screening rates, disparities in screening, treatment, and survival persist and it
remains third in terms of cancer incidence and mortality. (Gellad & Provenzale, 2010) The
reports of decreasing cancer mortality are specific to the cancer and do not include all-cause
mortality. Thus, although individuals diagnosed with CRC have improved cancer-specific
mortality, reducing all-cause mortality in CRC with comorbid conditions has become
increasingly important. (Gross et al., 2006)
The majority of new CRC diagnoses occur in older individuals, with more than twothirds diagnosed in those over the age of 65 years. (Everhart & Ruhl, 2009; Ries et al., 2007;
Rim, Seeff, Ahmed, King, & Coughlin, 2009)Comorbidity, or illnesses other than the primary
illness under treatment, is more common in the elderly. (Shack, Rachet, Williams, Northover, &
Coleman, 2010) Older individuals also often present with chronic conditions that complicate the
diagnostic and clinical management of CRC which leads to poorer prognosis and outcomes of
the cancer. (Satariano & Silliman, 2003; Yancik et al., 1998)The three most common comorbid
conditions seen in elderly patients with CRC are congestive heart failure, chronic obstructive
pulmonary disease and diabetes mellitus. (Gross et al., 2006)
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Numerous epidemiological and few pathophysiological studies have reported a positive
association between diabetes and CRC. (Elwing, Gao, Davidson, & Early, 2006; Giovannucci,
2001; Hu et al., 1999; Jin, 2008; Limburg et al., 2005; Limburg et al., 2006; McKeown-Eyssen,
1994; Vinikoor et al., 2009; Will, Galuska, Vinicor, & Calle, 1998) Poorly controlled type 2
diabetes independently predicts early onset of CRC, a more advanced stage at the time of
presentation, and a poorer 5-year survival. (Siddiqui et al., 2008). The influence of diabetes
mellitus on the mortality of patients with established colorectal cancer has been demonstrated by
various authors but with conflicting conclusions. Results from a clinical trial in 2003 were the
first to document that even after adjustment for other predictors of colon cancer, patients with
diabetes and high-risk stage II or stage III colon cancer experienced a significantly higher rate of
overall cancer mortality and cancer recurrence than non-diabetics. (Meyerhardt et al., 2003) Only
one other prospective study in the United States has investigated this relationship finding a
similar positive association. (Coughlin, Calle, Teras, Petrelli, & Thun, 2004). These studies are
limited by either their small, younger sample that did not have other debilitating chronic diseases
or relied on self-report data as end points. Retrospective studies have mixed conclusions about
whether or not pre-existing diabetes affects CRC mortality. A study conducted in elderly patients
in the Netherlands found that with co-morbidities such as diabetes, patients were treated less
aggressively and had a worse survival than those with no concomitant disease. (Lemmens et al.,
2005). Other retrospective cohort studies have concluded that diabetes did not affect short-term
survival or cancer specific survival, or were inconclusive. (Shonka et al., 2006) (Gross et al.,
2006; Jullumstro, Kollind, Lydersen, & Edna, 2009)
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Treatment for cancer can greatly affect mortality and short as well as long term survival
in patients with CRC. (Gill et al., 2004; Iwashyna & Lamont, 2002) Surgical resection is the only
curative treatment of colorectal cancer, performed as an open, surgical procedure requiring
hospitalization. (Mitry, Barthod, Penna, & Nordlinger, 2002; Redaelli, Cranor, Okano, & Reese,
2003) Potentially fatal complications of colorectal cancer include bowel perforation, peritonitis,
and obstruction. These complications are considered surgical emergencies and are the initial
presentation of colorectal cancer in an estimated 15% to 30% of patients with colorectal cancer.
(Diggs, Xu, Diaz, Cooper, & Koroukian, 2007). In addition, patients with emergency room
presentation of CRC have an increased 30-day mortality and decreased 5-year survival compared
to those scheduled for elective surgery. (Mitchell, Inglis, Murdoch, & Porter, 2007). The
Colorectal Cancer Collaborative Group in England reported that outcomes of surgery in elderly
patients are worse than those in younger patients because they were more likely to have
increased frequency of comorbid conditions, later-stage at presentation with the disease, and
undergo emergency surgery, and less likely to have curative surgery than younger patients.
(Colorectal Cancer Collaborative Group, 2000)
Although elective surgical resection is the curative treatment for CRC, a proportion of
patients present as surgical emergencies, which is a sign of failure to screen in a timely fashion.
(Rabeneck, Paszat, & Li, 2006) Patients with a new diagnosis of CRC who present with
obstruction, or perforation, or those who require emergency admission to hospital have more
advanced disease. (Scott, Jeacock, & Kingston, 1995). Patients who are admitted emergently also
have worse survival rates than those who are not. (Kim et al., 2007; Paulson, Wirtalla,
Armstrong, & Mahmoud, 2009; Smothers et al., 2003) However, these reports are however from
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studies that have included a small sample of patients from local hospitals that are not nationally
representative.
Chemotherapy is used in patients at risk for metastases and those with poor prognosis
following surgery. (Redaelli et al., 2003) Evidence from clinical trials suggests that adjuvant
chemotherapy is associated with a 34% reduction in mortality, and population-based
observational studies have demonstrated similar survival benefits. (Gill et al., 2004) Prior work
also has suggested that the survival benefits associated with adjuvant therapy do not diminish
with increasing age. (Iwashyna & Lamont, 2002) Previous evidence has shown that although a
survival benefit was seen in diabetic patients who received chemotherapy rather than those
diabetic patients who did not, presence of diabetes significantly reduced the use of adjuvant
chemotherapy. (Gross, McAvay, Guo, & Tinetti, 2007)
Therefore, besides having a comorbid condition such as diabetes, type of treatment,
emergency admission, stage at diagnosis, age and other comorbid conditions play an important
role in the survival of the colorectal cancer patient. No study has examined these factors together
in a large nationally representative sample. The primary objective of the study is to explore the
effect of diabetes on survival of elderly Medicare beneficiaries with CRC. A secondary objective
is to explore the association of the covariates including the three most common comorbid
conditions, in addition to diabetes (congestive heart failure (CHF), chronic obstructive
pulmonary disease (COPD), and coronary atherosclerosis), emergency admission, and treatment
variables (chemotherapy/radiation and surgery), and how they affect survival in a CRC patient.
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Methods
Data
This retrospective cross sectional analysis employed the Surveillance, Epidemiology and
End Results-Medicare (SEER-Medicare) files for the years 2003 to 2005. The data come from
the SEER program of cancer registries that collect clinical, demographic, mortality and survival
for persons with cancer and the Medicare claims for covered health care services from the time
of a person's Medicare eligibility until death. The SEER-Medicare data reflect the linkage of two
large population-based sources of data that provide detailed information about Medicare
beneficiaries with cancer. The linkage of these two data sources results in a unique populationbased source of information that can be used for an array of epidemiological and health services
research. Previous work has demonstrated excellent agreement among data sources in case
ascertainment. (Potosky, Riley, Lubitz, Mentnech, & Kessler, 1993) Currently, SEER has 17
high quality registries participating in the program, representing 12 states, and with the Medicare
data it effectively represents the elderly population of the entire United States. (Warren,
Klabunde, Schrag, Bach, & Riley, 2002)
Cohort
Patients with a newly diagnosed malignant adenocarcinoma of the colon or rectum were
identified in the SEER-Medicare database between the years 2003-2005. With the stipulated
inclusion criteria of 1) only one primary cancer, 2) eligibility for both Part A and B benefits for
at least 12 months prior to cancer diagnosis, and 3) did not die in the same month as their cancer
diagnosis, there were 30,340 cases aged 66 and over. Sixty-six was selected as the cut-off to
ensure that each person would have at least 12 months of Medicare claims prior to the diagnosis
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of CRC. Cases with unknown race were eliminated (N= 38). Cases were further deleted if the
source of information was from autopsy or death certificate only (N= 9). Finally, cases were
deleted because their cancer stage was zero or unknown (N=5,059). The final cohort consists of
25,234 patients.
Variables
Diabetic patients were identified using inpatient, outpatient, and physician claims for
each patient during a period of 12 months before diagnosis of CRC. To maximize specificity a
patient was identified as diabetic if he or she had at least one inpatient claim or two outpatient
claims for diabetes. (Hebert et al., 1999) This process provides a specificity of 98.8%. Comorbid
conditions were searched using similar criteria and the three most common chronic conditions
i.e. CHF, Coronary Atherosclerosis, and COPD were selected to be included as covariates.
SEER reports disease stage using the third edition of the American Joint Committee on
Cancer (AJCC) definition for the 2003 cases and AJCC Cancer Staging Manual 6th edition
definition for cases diagnoses in 2004 and 2005. Comprehensive stage categories were collapsed
into stages I, II, III and IV. Stage at diagnosis for colorectal cancer directly affects mortality and
survival. Chances for survival are more than 90% for Stage I, 82% for Stage II, 57% for Stage III
and drop to 6% for Stage IV patients. (Gloeckler Ries, L.A. 2003) Due to these differential
survival rates between the stages, patients were categorized as being “Early Stage” (Stage I and
II) or “Late Stage” (Stages III and IV) patients.
Age was categorized as 66-69 years, 70-74 years, 75-79 years, 80-84 years, and 85 years
and over. Race was categorized as white, black, and other. SEER areas to which the patients
belonged were categorized as west, mid-west, south, and east depending on the region in the US.
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Location of the tumor was categorized as proximal (cecum to splenic flexure) and distal
(descending colon to rectum). The categorization was based on the ease of cancer detection
based on the method used for screening or diagnosis. Proximal cancers are identified primarily
through the use of colonoscopy, unlike a sigmoidoscopy which would be unable to reach these
areas. The number of physician office visits 12 months prior to cancer diagnosis was identified
and the continuous variable was transformed into quintiles of office visits with the first quintile
representing the highest number of office visits. Patients admitted emergently were identified as
“emergency admission”.
Surgery for CRC, within 12 months after cancer diagnosis, was identified by using the
International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)
procedure codes for colon resection (codes 45.7x and 45.8), rectal resection (codes 48.4x, 48.5,
48.6x), and other operations on the intestine including colostomy and ileostomy (codes 46.1-2).
(Diggs et al., 2007; Etzioni, Beart, Madoff, & Ault, 2009; Hayanga et al., 2010) Since radiation
claims formed only a small percentage of treatment claims in the Medicare files, chemotherapy
and radiation received within 12 months after cancer diagnosis were collapsed to create the
variable “chemotherapy/radiation”.
Statistical Analysis
The advantage of using survival statistics is that it considers when the patient was
diagnosed, stage at diagnosis and the kind of treatment given in the stipulated time period. (Ries
2007) Patients that were newly diagnosed with CRC between 2003 and 2005 were examined up
December 31st 2007 in this study which gives a follow up period of up to 5 years or 60 months.
Mortality, on the other hand measures deaths due to cancer in a given time period, irrespective of
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when patients were diagnosed, and does not take into consideration treatment options. (Ries
2007) Hence for this study survival analysis techniques were employed.
Univariate statistics were used to describe the sample and bivariate statistics were used
to explore the proportion of patients distributed between diabetics and nondiabetics. Pearson’s
chi-square statistic was used for the bivariate analysis. Cox proportional hazards models were
used to examine the association between each patient characteristic and all cause mortality
during the follow-up period. Data were censored at death or the end of calendar year 2007,
whichever occurred first. Candidate covariates for the multivariate model included
sociodemographic characteristics, cancer-specific characteristics (stage, tumor location), and
individual conditions. To address variability in use of care the number of physician outpatient
visits 12 months before cancer diagnosis was included in the model. To determine whether
treatment differences mediated the relationship between specific chronic conditions and death,
the analysis was repeated after adding cancer treatment–related variables to the model. All
analyses were performed using IBM SPSS version 20.

Results
In a sample of 25,234 patients with newly diagnosed CRC from 2003 to 2005 there were
5.466 diabetics (21.7%). The mean age of the study cohort was 77.5 years (range 66 to 114) and
there were 55.1% females. Patients were evenly distributed between all stages with 25%
diagnosed at stage I, 30.4% at stage II, 26.1% at stage III, and 18.5% at stage IV. Tumors were
equally divided as well, with 50.2% located in the proximal area of the colon. There were 18.0%
patients who were admitted emergently.
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Table 1 shows the distribution of patients by patient characteristic. The highest
proportion of patients by age belonged to 75-79 years group (23.8%), and a majority of the
patients were white (84.8%). Presence of coronary atherosclerosis, COPD and CHF were 21.5%,
11.1%, and 10.9% respectively. Emergency admission was represented by 18.0% of the cohort.
Most of the newly diagnosed patients underwent surgery (83.5%), and the number of patients
that received chemotherapy or radiation was 34.5%. A majority of patients belonged to Western
US (40.6%) and resided in a large metropolitan area (55.1%).
Distribution of patients by diabetes status shows that with increasing age prevalence of
diabetes increases, peaks between ages 75-79 years and then declines thereafter (Table 2). There
were more diabetic males than females, and compared to Whites, Blacks, or Other races tended
to have a greater proportion of the disease. Although diabetics were more likely to be diagnosed
at early stages, they were also more likely to be admitted emergently. A greater proportion of
diabetics underwent surgery for CRC with no difference seen in chemotherapy or radiation
treatments between diabetics and nondiabetics. Diabetics also had a higher frequency of
physician office visits than nondiabetics.
Table 3 shows the proportions of patients who died by comorbid conditions, treatment
variables and demographic characteristics. Diabetic patients were significantly more likely to die
within the five year period than nondiabetics, Similar results were seen in patients suffering from
coronary atherosclerosis, COPD and CHF. Patients with late stage at diagnosis and distal tumor
location were also more significantly more likely to die than those with early stage diagnosis and
proximal tumors. Patients admitted emergently were more likely to die than those who were not.
In this bivariate analysis although surgery had a beneficial effect on mortality, chemotherapy or
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radiation did not. Finally only patients with the greatest number of office visits were more likely
to die compared to those with the lowest number of office visits.
The mortality risk (represented by hazard ratios or HR in Table 4) associated with
diabetes in the cox proportional hazards model was significantly greater for diabetics than
nondiabetics (HR 1.15, 95% CI 1.09-1.20). This was seen for COPD (HR 1.33, 95% CI 1.261.41) and CHF (HR 1.43, 95% CI 1.35-1.52). Risk of mortality significantly increased with age
with the HR for those over the age of 85 being more than twice as compared to those between
66-69 years (HR 2.30, 95% CI 2.14-2.47). Women had a lower risk than men (HR 0.92 955 CI
0.89-0.96) and Blacks had an 8% higher risk than Whites (HR 1.08, 95%CI 1.01-1.15).
Presenting emergently significantly increased the risk of mortality (HR 1.61, 95% CI 1.54-1.68).
Surgery significantly reduced the risk of mortality (HR 0.41, 95% CI 0.39-0.43) and although in
bivariate analyses patients who received chemotherapy were more likely to die, the hazard model
showed a significant benefit associated with chemotherapy or radiation (HR 0.70, 95% CI 0.670.74). Patients with the highest number of office visits had improved risk of mortality compared
to those with lower number of office visits.
Kaplan-Meier survival curves for diabetics, emergency admission patients, patients who
underwent surgery and chemotherapy/radiation recipients are shown in Figs 1-4. The survival
curve for surgery clearly shows a benefit beginning in the first year itself. Although there is a
benefit seen in patients receiving chemotherapy/radiation, it is more pronounced only in later
years. Diabetics clearly had a poorer survival benefit compared to nondiabetics which worsened
with time. Those who were admitted emergently had lower survival from the time of diagnosis
which progressively worsened with time compared to those who were not admitted emergently.
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Discussion

This study was conducted to explore the effect of diabetes on survival of elderly
Medicare beneficiaries with CRC. The study also explores the association of the covariates
including the three most common comorbid conditions (coronary atherosclerosis, CHF, and
COPD), in addition to diabetes, emergency admission, and treatment variables and how they
affect survival in a CRC patient.
The study shows that diabetics suffered worse mortality and survival than nondiabetics.
Several factors need to be considered while interpreting this result. First, lack of mortality as
well as survival benefit in diabetics is seen despite them being in the highest bracket of physician
office visits. Increased number of office visits and visits with primary care physicians in elderly
Medicare beneficiaries have previously been associated with increased CRC test use. (Schenck et
al., 2011) Klabunde and colleagues have reported that having a chronic condition such as
diabetes is a predictor of receiving a physician recommendation for CRC screening. (Klabunde,
Schenck, & Davis, 2006)(Klabunde et al., 2006) Increased number of physician office visits
increases the chances of being recommended for a screening test and clinician recommendation
for a screening test has been proven to be a strong predictor of adherence to CRC screening in
the elderly as well as young patients to adhere to screening practices for CRC. (Felsen, Piasecki,
Ferrante, Ohman-Strickland, & Crabtree, 2011; Gilbert & Kanarek, 2005) Second, although
diabetics visited physician offices more frequently they were also admitted more emergently for
CRC than non-diabetics. This study shows that there is a significant mortality risk associated
with being admitted emergently. Besides being a sign of screening failure, emergent admissions
have poorer outcomes than non-emergent admissions for CRC. Last, despite controlling for the
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treatment variables surgery and chemotherapy/radiation, which provide significant survival
benefit, the study shows a decrease in survival benefit in diabetics.
Although it has been advised that among CRC patients, preexisting diabetes is associated
with a higher risk of all-cause long-term mortality, this is the first study that explores this
association in light of the aforementioned factors. Besides these factors it has been shown that
because diabetes can lead to infections, metabolic derangements, and acute cardiovascular
events, cancer patients, including those with CRC, diabetics may also be at a greater risk of
short-term mortality, especially while surgery is being performed and even after surgery.
(Richardson & Pollack, 2005) A recent meta-analysis by Barone and colleagues concluded that
compared to nondiabetics, cancer patients with preexisting diabetes are approximately 50% more
likely to die after surgery. (Barone et al., 2010) They mention that this could be due to sepsis and
other serious infections which could increase in diabetics especially after surgery due to a
possible rise in blood sugar levels.
This study shows that patients with fewer office visits had a survival benefit. This could
be explained by the fact that those with fewer office visits had fewer comorbid conditions in the
first place and hence were predisposed to having a better prognosis and outcome. In addition, it
has also been previously reported that elderly patients with CRC increase rather than decrease
contact with primary care providers after diagnosis which continues through the first 5 years
after cancer diagnosis. (Dobie, Saver, Wang, Green, & Baldwin, 2011) However, this still does
not fully explain the reason for lack of survival benefit seen in those with the highest frequency
of office visits. This is an issue for further research that needs to be explored.
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This study is the first to report emergency admission and its risk associated with mortality
and survival in a large group of elderly, nationally representative population of CRC patients.
Despite implementation of national intervention strategies, up to 30% percent of CRC patients
are admitted emergently. (Kim et al., 2007; Polednak, 2000; Smothers et al., 2003) In this study
diabetics presented more emergently than not. This clearly signifies failure to screen in a timely
fashion and a possible failure of screening interventions and strategies. Diabetics also have worse
survival than nondiabetics. Since diabetic CRC patients have worse outcomes than their
nondiabetic counterparts they must take advantage of the fact that the cancer can be prevented
with timely screening. Current screening guidelines do not consider diabetics as a special case
for earlier screening or more frequent CRC screening. McBean and Yu have reported that elderly
diabetic women are less likely than elderly non-diabetic women to receive colorectal cancer
screening in the 11 SEER areas studied between 1999-2002. (McBean & Yu, 2007) They have
furthered the argument in favor of altering CRC screening guidelines for diabetics by mentioning
that the American Diabetes Association (ADA) should include specific screening
recommendation for such cancers in the Standards of Medical Care in Diabetes. They also
suggest combining specific recommendations for people with diabetes in guidelines from federal
or national organizations that promote the use of screening services but are not primarily or
uniquely concerned with diabetes such as the CDC, the National Cancer Institute, the American
Cancer Society, and the CMS.
This study has some limitations which must be considered in the interpretation of
results. The study used previously employed algorithms to identify diabetic patients. However,
the duration of diabetes as well as clinical values such as HbA1C which may have significantly
affected the stage at which patients were diagnosed with CRC, were not available. Siddiqui et al
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have reported that uncontrolled diabetes and therefore increased HbA1C levels leads to diagnosis
of CRC at later stages than diabetes that is under control. (Siddiqui et al., 2008) Timely
screening plays a crucial role in detecting the cancer at earlier stages and the data did not allow
us to check for frequency of screening. This is especially true for sigmoidoscopy and
colonoscopy procedures which are recommended to be performed at five year and ten year
intervals, respectively. In addition, SEER–Medicare data do not include other important
measures of health status, such as body mass index, diet, functional disabilities or geriatric
syndromes.
The study also has several strengths including stringent inclusion and exclusion criteria,
and the use of population based data from a cancer registry that is globally recognized as an
authoritative source of information on cancer incidence in the United States. Detailed
demographic, cancer data on stage and tumor location, and treatment variables allowed the
construction of a strong Cox proportional hazards model to study and understand the mortality
risk associated with diabetes and the several covariates in CRC patients.
Diabetes has a poor effect on the survival and all-cause mortality of patients with CRC.
Emergency admission and stage at diagnosis has a large effect on survival and therefore
underscore the importance of early diagnosis. Diabetic patients should be screened and
diagnosed in a timely fashion to prevent CRC or to have a better disease prognosis.
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Table 1. Characteristics of the sample*
N
%
Characteristic
Age
66-69
70-74
75-79
80-84
85 & over

4031
5411
6017
5302
4473

16.0
21.4
23.8
21.0
17.7

11329
13905

44.9
55.1

21396
2097
1741

84.8
8.3
6.9

19768
5466

78.3
21.7

19797
5437

78.5
21.5

22443
2791

88.9
11.1

22474
2760

89.1
10.9

6312
18922

25.0
75.0

20699
4535

82.0
18.0

4152
21082

16.5
83.5

16522
8712

65.5
34.5

Sex
Male
Female
Race
White
Black
Other
Diabetes
No
Yes
Athero
No
Yes
COPD
No
Yes
CHF
No
Yes
Stage
Early
Late
Emergency Admission
No
Yes
Surgery
No
Yes
Chemotherapy/Radiation
No
Yes

Continued
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Table 1. Characteristics of the sample*
Region in US
West
10245 40.6
Midwest
3947 15.6
South
4756 18.8
East
6286 24.9
Patient Location
Big Metro
Metro
Urban
Less Urban
Rural

13913
7071
1556
2188
506

55.1
28.0
6.2
8.7
2.0

*Sample equals 25,234 CRC patients
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Table 2 Characteristics of patients by diabetes status
Patient Characteristic

Diabetes
No
N %

Age Group
66-69
70-74
75-79
80-84
85 & over
Sex
Male
Female
Race
White
Black
Other
Atherosclerosis
No
Yes
COPD
No
Yes
CHF
No
Yes
Stage
Early
Late
Tumor Location
Distal
Proximal
Emergency Admission
No
Yes
Surgery
No
Yes
ChemRad
No
Yes

p
Yes
N %
0.000

3135
4154
4561
4239
3679

15.9%
21.0%
23.1%
21.4%
18.6%

896
1257
1456
1063
794

16.4%
23.0%
26.6%
19.4%
14.5%

8718
11050

44.1%
55.9%

2611
2855

47.8%
52.2%

17050
1491
1227

86.3%
7.5%
6.2%

4346
606
514

79.5%
11.1%
9.4%

16273
3495

82.3%
17.7%

3524
1942

64.5%
35.5%

17729
2039

89.7%
10.3%

4714
752

86.2%
13.8%

18076
1692

91.4%
8.6%

4398
1068

80.5%
19.5%

10917
8851

55.2%
44.8%

3071
2395

6.2%
43.8%

9852
9916

49.8%
50.2%

2707
2759

49.5%
50.5%

16288
3480

82.4%
17.6%

4411
1055

80.7%
19.3%

3357
16411

17.0%
83.0%

795
4671

14.5%
85.5%

12911
6857

65.3%
34.7%

3611
1855

66.1%
33.9%

0.000

0.000

0.000

0.000

0.000

0.207

0.681

0.004

0.000

0.302

Continued
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Table 2 Characteristics of patients by diabetes status
Patient Characteristic

Diabetes
No
N %

Region in the US
West
Midwest
South
East
Patient Location
Big Metro
Metro
Urban
Less Urban
Rural
Quintile of Physician
Visits
First (Highest)
Second
Third
Fourth
Fifth (Lowest)

p
Yes
N %
0.000

8181
3079
3733
4775

41.4%
15.6%
18.9%
24.2%

2064
868
1023
1511

37.8%
15.9%
18.7%
27.6%

10838
5539
1241
1748
402

54.8%
28.0%
6.3%
8.8%
2.0%

3075
1532
315
440
104

56.3%
28.0%
5.8%
8.0%
1.9%

3230
3767
3853
4125
4793

16.3%
19.1%
19.5%
20.9%
24.2%

1867
1465
1130
782
222

34.2%
26.8%
20.7%
14.3%
4.1%

0.141

0.000

*Patients are representative of 19,768 nondiabetics and 5,466 diabetics

99

Neel Shah

Dissertation

Table 3 Characteristics of patients by mortality status
Patient Characteristic

Died
No
N %

Age Group
66-69
70-74
75-79
80-84
85 & over
Sex
Male
Female
Race
White
Black
Other
Diabetes
No
Yes
Atherosclerosis
No
Yes
COPD
No
Yes
CHF
No
Yes
Stage
Early
Late
Tumor location
Distal
Proximal
Emergency Admission
No
Yes

p
Yes
N %
0.000

2755
3435
3505
2702
1683

19.6%
24.4%
24.9%
19.2%
12.0%

1276
1976
2512
2600
2790

11.4%
17.7%
22.5%
23.3%
25.0%

6269
7811

44.5%
55.5%

5060
6094

45.4%
54.6%

11979
1032
1069

85.1%
7.3%
7.6%

9417
1065
672

84.4%
9.5%
6.0%

11191
2889

79.5%
20.5%

8577
2577

76.9%
23.1%

11302
2778

80.3%
19.7%

8495
2659

76.2%
23.8%

12867
1213

91.4%
8.6%

9576
1578

85.9%
14.1%

13059
1021

92.7%
7.3%

9415
1739

84.4%
15.6%

9977
4103

70.9%
29.1%

4011
7143

36.0%
64.0%

6917
7163

49.1%
50.9%

5642
5512

50.6%
49.4%

12293
1787

87.3%
12.7%

8406
2748

75.4%
24.6%

0.182

0.000

0.000

0.000

0.000

0.000

0.000

0.022

0.000

Continued
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Table 3 Characteristics of patients by mortality status
Patient Characteristic

Died
No
N %

Surgery
No
Yes
Chemo-Radiation
No
Yes
Region in the US
West
Midwest
South
East
Patient Location
Big Metro
Metro
Urban
Less Urban
Rural
Quintile of Physician
Visits
First (Highest)
Second
Third
Fourth
Fifth (Lowest)

p
Yes
N %
0.000

1426
12654

10.1%
89.9%

2726
8428

24.4%
75.6%

9349
4731

66.4%
33.6%

7173
3981

64.3%
35.7%

5843
2245
2515
3477

41.5%
15.9%
17.9%
24.7%

4402
1702
2241
2809

39.5%
15.3%
20.1%
25.2%

7717
3997
877
1208
281

54.8%
28.4%
6.2%
8.6%
2.0%

6196
3074
679
980
225

55.5%
27.6%
6.1%
8.8%
2.0%

14080
2443
2961
2969
3014
2693

17.4%
21.0%
21.1%
21.4%
19.1%

11154
2654
2271
2014
1893
2322

23.8%
20.4%
18.1%
17.0%
20.8%

0.001

0.000

0.615

0.000

*Patients are representative of 14,080 who did not die and 11,154
who died
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Table 4. Cox Proportional Hazards Model for time to mortality in CRC patients
over a 5 year period
95.0% CI for HR
Patient Characteristic
Comorbidities

Age Group

Sex
Race

Admission Type
Treatment

Tumor Location
Stage
Region in the US

Patient Location

Quintile of Office
Visits

HR
1.12
0.98

Lower
1.06
0.94

Upper
1.17
1.03

p
.000
.482

Sig
***

COPD
CHF
66-69
70-74
75-79
80-84
85 and over

1.33
1.43

1.26
1.35

1.41
1.52

1.18
1.42
1.72
2.30

1.10
1.33
1.60
2.14

1.27
1.52
1.84
2.47

.000
.000
.000
.000
.000
.000
.000

***
***
***
***
***
***
***

FEMALE
White
Black
Other
Emergency

0.92

0.89

0.96

1.08
0.85
1.61

1.01
0.78
1.54

1.15
0.92
1.68

.000
.000
.020
.000
.000

***
***
***
***
***

Surgery
Chemo/Rad

0.41
0.70

0.39
0.67

0.43
0.74

.000
.000

***
***

Proximal
Late Stage
WEST
MIDWEST
SOUTH
EAST
Big Metro
Metro
Urban
Less Urban

0.94
3.74

0.91
3.59

0.98
3.91

***
***
***

0.97
1.11
0.93

0.91
1.05
0.88

1.03
1.18
0.97

0.92
0.93
0.95

0.80
0.81
0.82

1.05
1.06
1.11

.003
.000
.000
.252
.000
.002
.663
.214
.273
.530

Rural
First Quintile
(Highest)
Second
Third
Fourth
Fifth (Lowest)

0.94

0.82

1.09

.420
.000

0.89
0.87
0.84
0.93

0.84
0.82
0.79
0.87

0.94
0.92
0.90
1.00

.000
.000
.000
.042

Diabetes
Atherosclerosis

***
***

***
***
***
***

Referent categories for Diabetes, COPD, Athero and CHF are no diabetes, no
Athero, no COPD and no CHF
Referent category for sex is MALE, Tumor location is distal, Stage is early stage,
and for treatment is no surgery and no Chemo/rad
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Not Diabetic
P = 0.000
Diabetic
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Non-Emergency

Emergency
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Surgery

P = 0.000

No
Surgery
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Chem/Rad

P = 0.000
No
Chem/Rad
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CHAPTER FIVE
DISCUSSION

To explore the outcomes of CRC in diabetic elderly patients the study used a large
nationally representative sample and focused on main aims. The first aim was to investigate the
association between diabetes and stage at diagnosis of CRC in an elderly population. The
association of covariates such as the three most common comorbidities: coronary atherosclerosis,
chronic obstructive pulmonary disease (COPD), and congestive heart failure (CHF); age; race;
sex; region in the US; patient location; and the frequency of physician office visits with stage at
CRC diagnosis was also evaluated.
The second aim was to check the association of diabetes with CRC presenting as an
emergency condition for surgery in the elderly. This was followed by an investigation of
predictors of emergency condition of CRC surgery in the elderly using large nationally
representative registry data. The predictors that were explored included were the three most
common comorbidities: coronary atherosclerosis, chronic obstructive pulmonary disease
(COPD), and congestive heart failure (CHF); age; race; sex; region in the US; patient location;
the frequency of physician office visits; and stage at CRC diagnosis.
Finally, the study explored the effect of diabetes on survival of elderly Medicare
beneficiaries with CRC. It also explored the association of the covariates including three most
common comorbid conditions, in addition to diabetes, emergency admission, and treatment
variables and how they affect survival in a CRC patient.
For all three aims, the linked Surveillance, Epidemiology and End-Results (SEER)Medicare data which is a large population-based source of information for cancer-related
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epidemiologic and health services research was utilized. The use of the SEER-Medicare data
consists of CRC cases from 17 registries from 2003-2005, and provides several strengths such as
exploring a nationally representative elderly population. This is unique since previous studies
have studied the disease in either smaller regions of the country, fewer registries, or have
included patients that were not elderly. This is also the first study to explore the association of
diabetics with stage at diagnosis of CRC in such a large representative sample in the US. The
association of diabetes with emergency condition for CRC surgery including bowel perforation,
bowel obstruction, and peritonitis has never before been studied in an elderly population; this
study investigates this along with relevant covariates. The association of diabetes, other
frequently seen chronic comorbid conditions, emergency admissions and treatment variable,
along with tumor location, office visits, region and other demographic characteristics finally
come together to check survival and mortality in this unique sample.

Diabetes and Stage at Diagnosis
The association of diabetes with stage at diagnosis of CRC has been previously
studied in the US and other countries in smaller samples with conflicting results. In this study
diabetes does not show a significant association with stage at diagnosis for CRC. If left
uncontrolled, diabetes outcomes in CRC patients are even worse than those with controlled
diabetes. (Siddiqui, A.A. 2008) In addition, diabetic CRC patients tend to have poorer outcomes
than non-diabetic patients, and therefore it can be argued that the cancer should be detected at an
earlier stage in diabetics than in non-diabetics due to the survival benefit provided at being
treated at earlier stages.
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This study also showed that diabetics visited physicians more frequently than nondiabetics and were more likely to have comorbid conditions such as coronary atherosclerosis,
COPD and CHF. This would predispose them to greater recommendations for screening for
various diseases including CRC and therefore it would be reasonable to expect them to be
diagnosed at earlier stages than non-diabetics. However, after adjusting for the number of
physician office visits this was not so. A review of barriers and facilitators to screening for CRC
in patients over the age of 65 suggests that although Medicare's coverage
of screening colonoscopy was consistently reported as a facilitator, the most cited barrier was
lack of screening recommendation by a physician. (Guessous, I. 2010) Compared to average risk
patients, i.e. patients over the age of 50 with no chronic diseases or history of cancer, diabetics
are considered as increased-risk for colorectal cancer. A recent study that examined screening
patterns in individuals with varying risk for CRC found that compared to average risk patients,
diabetics were less likely to be recommended by physicians for CRC screening and were also
less likely to be adherent to a recommendation if one was made. (Felsen, C.B. 2011)
It is important to note that patients over the age of 80 are more likely to be diagnosed at a
later stage than younger patients. This could be due to some guidelines cautioning against use of
invasive methods for screening for patients over the age of 75 due to possible adverse effects of
screening. (Qaseem,A. 2012) All guidelines specifically do not recommend using any invasive
method for screening patients over the age of 85.
The results in this study show that tumors detected within the proximal region in the
colon are found to have progressed much more than the ones located in the distal region. Distal
tumors are easier to detect with less invasive procedures such as sigmoidoscopy which cannot
look at the large intestine in its entirety and is recommended more frequently than colonoscopies.
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Although, both invasive procedures are equally sensitive, sigmoidoscopes cannot reach the
proximal areas of the large intestine leading to tumors in those areas to go undetected. (Schoen,
R.E. 2012) Proximal tumor location, even after controlling for stage, has also been significantly
associated with poorer mortality and survival as compared to distally located colon cancers.
(Wray, C.M. 2009)

Diabetes and Emergency Condition for CRC surgery
This study is the first to report the association of diabetes with emergency surgery
for CRC, and explore the predictors of emergency colorectal cancer surgery in a large nationally
representative sample. The study showed that the odds of being an emergency patient for CRC
surgery were lower for diabetic patients; this association was not significant. However, this result
must be interpreted in light of the fact that diabetic patients belonged to the highest quintile in
terms of physician office visits. Previous reports on a Medicare population have mentioned that
having any physician office visit, increased number of office visits, and visits with primary care
physicians were associated with increased CRC test use.(Schenck et al., 2011) Klabunde and
colleagues have reported that having a chronic condition such as diabetes is a predictor of
receiving a physician recommendation for CRC screening.(Klabunde, Schenck, & Davis, 2006)
Increased number of physician office visits increases the chances of being recommended for a
screening test; and clinician recommendation for a screening test has been proven to be a strong
predictor in the elderly as well as young patients to adhere to screening practices for
CRC.(Felsen, Piasecki, Ferrante, Ohman-Strickland, & Crabtree, 2011; Gilbert & Kanarek,
2005)
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Compared to Whites, Black patients were more likely to be classified as an emergency
condition for CRC surgery. It has been reported that Blacks, Hispanics, and American
Indians/Alaska Natives were less likely to report receiving a recommendation for sigmoidoscopy
compared to Whites.(Coughlin & Thompson, 2005) Whites are also more likely than Blacks to
report ever receiving a provider recommendation for a colonoscopy. Although the proportion of
patients receiving recommendations for colonoscopy/sigmoidoscopy increased over time, the gap
between races remained unchanged, even after controlling for insurance status.(Rich et al., 2011)
A study by Hood and colleagues has reported that although over 80% of their sample of 439
blacks was covered by insurance, less than 50% reported receiving a recommendation to screen
for CRC.(Hood et al., 2010)
Once again the intermediate outcome for the elderly patients over the age of 80 was
poorer with the odds of being an emergency case for CRC surgery being higher for this group.
This could, again, be due to several guidelines cautioning against use of invasive methods for
screening for patients over the age of 75 and all guidelines specifically not recommending using
any invasive method for screening patients over the age of 85 due to possible adverse effects of
screening.(Qaseem et al., 2012)
The results of this study also showed that having a proximal tumor decreased the odds of
being an emergency case for CRC surgery. This study is the first to report an association
between tumor location and emergency condition for surgery for CRC. However, it has been
reported that screening for CRC does not have a survival benefit in patients with proximal
cancers despite recent epidemiologic studies suggesting an overall shift to more proximal sites of
colon cancer distribution.(Wong, 2010) Proximal cancer tumor biology also makes it hard for
them to be detected. There are underlying differences in the biology of proximal and distal CRC
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neoplasia that may contribute to the variable effectiveness of colonoscopy.(Baxter, Warren,
Barrett, Stukel, & Doria-Rose, 2012) This may mean that proximal tumors were possibly
underrepresented in the sample in this study.
Diabetics and CRC mortality and survival
In the analysis to explore the effect of diabetes on survival of elderly Medicare
beneficiaries with CRC which also investigated the association of the covariates including three
most common comorbid conditions, in addition to diabetes, emergency admission, and treatment
variables, the study shows that diabetics suffered worse mortality and survival than nondiabetics.
Several factors need to be considered while interpreting this result. Firstly, lack of mortality as
well as survival benefit in diabetics is seen despite them being in the highest bracket of physician
office visits. Increased number of office visits, and visits with primary care physicians in elderly
Medicare beneficiaries have previously been associated with increased CRC test use. (Schenck et
al., 2011) Klabunde and colleagues have reported that having a chronic condition such as
diabetes is a predictor of receiving a physician recommendation for CRC screening. (Klabunde,
Schenck, & Davis, 2006)(Klabunde et al., 2006) Increased number of physician office visits
increases the chances of being recommended for a screening test; clinician recommendation for
a screening test has been proven to be a strong predictor in the elderly as well as young patients
to adhere to screening practices for CRC. (Felsen, Piasecki, Ferrante, Ohman-Strickland, &
Crabtree, 2011; Gilbert & Kanarek, 2005)
Secondly, although diabetics were the most frequent visitors to physician offices they
were also admitted more emergently for CRC than non-diabetics. This study shows that there is a
significant mortality risk associated with being admitted emergently. Besides being a sign of
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screening failure, emergent admissions have poorer outcomes than non-emergent admissions for
CRC.
Lastly, despite controlling for the treatment variables surgery and
chemotherapy/radiation, which provide significant survival benefit, the study shows a decrease
in survival benefit in diabetics. Although it has been advised that among CRC patients,
preexisting diabetes is associated with a higher risk of all-cause long-term mortality, this is the
first study that explores this association in light of the aforementioned factors.
Besides these factors it has been shown that because diabetes can lead to infections,
metabolic derangements, and acute cardiovascular events, cancer patients, including those with
CRC and diabetes may also be at greater risk of short-term mortality, especially while surgery is
being performed, and even after surgery. (Richardson & Pollack, 2005) A recent meta-analysis
by Barone and colleagues has concluded that compared to nondiabetics, cancer patients with
preexisting diabetes are approximately 50% more likely to die after surgery. (Barone et al., 2010)
They mention that this could be due to sepsis and other serious infections which could increase
in diabetics especially after surgery due to a possible rise in blood sugar levels.
This study is the first to report emergency admission and its risk associated with mortality
and survival in a large group of elderly, nationally representative population of CRC patients.
Despite implementation of national intervention strategies up to 30% percent of CRC patients are
admitted emergently. (Kim et al., 2007; Polednak, 2000; Smothers et al., 2003) In this study
diabetics presented more emergently than not. This clearly signifies failure to screen in a timely
fashion and a possible failure of screening interventions and strategies. Diabetics also have worse
survival than nondiabetics.
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Limitations
This study must also be interpreted in the lights of its limitations. The study used
previously employed algorithms to identify diabetic patients. However, the duration of diabetes
as well as clinical values such as HbA1C which may have significantly affected the stage at
which patients were diagnosed with CRC, were not available. Siddiqui et al have reported that
uncontrolled diabetes and therefore increased HbA1C levels leads to diagnosis of CRC at later
stages than diabetes that is under control.(Siddiqui et al., 2008) Most colorectal cancers start off
as benign adenomatous polyps that turn into adenocarcinomas over several years (cancers that
begin in cells that make and release mucus and other fluids). As many as 50% of the Western
populations develop adenomatous polyps in their lifetime but the lifetime risk for colon cancer is
about 5% and only one in ten adenomas lead to cancer formation (Holt, Kozuch, & Mewar,
2009). It cannot be determined which individuals with adenomas (or a histologically normal
colon at risk for adenoma and cancer formation) will develop a cancer and therefore, preventive
methods use detection and removal of benign neoplastic colorectal adenomas which lowers colon
cancer formation and mortality (Muller & Sonnenberg, 1995). This study was unable to
determine the duration and size of benign polyps, if any, in this sample which may have
influenced the time at which the cancer was detected, the stage and the prognosis of the disease.
Timely screening plays a crucial role in detecting the cancer at earlier stages and the data
did not allow us to check for frequency of screening. This is especially true for sigmoidoscopy
and colonoscopy procedures which are recommended to be performed at five year and ten year
intervals respectively. In addition, SEER–Medicare data do not include other important measures
of health status, such as body mass index, diet, functional disabilities or geriatric syndromes.
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Conclusions and Future directions
This study has several strengths including stringent inclusion and exclusion criteria, and
the use of population based data from a cancer registry that is globally recognized as an
authoritative source of information on cancer incidence and in the United States. Detailed
demographic, cancer data on stage and tumor location, and treatment variables allowed the
construction of a strong cox proportional hazards model to study and understand the mortality
risk associated with diabetes and the several covariates in CRC patients.
The association between diabetes and stage at colorectal cancer, although not statistically
significant in this study, must be further explored. Dialogue between the physician and diabetic
patient should be encouraged to discuss screening for CRC. Diabetic patients should be screened
for the cancer either more frequently or begin at an age earlier than the average risk patient in
order to detect the cancer at earlier stages. Patient physician interaction is of prime importance
and there needs to be improved intervention and strategies for escalating physician
recommendation in this subgroup of the population.
This study shows that patients with fewer office visits had a survival benefit. This could
be explained by the fact that those with fewer office visits had fewer comorbid conditions in the
first place and hence were predisposed to having a better prognosis and outcome. In addition, it
has also been previously reported that elderly patients with CRC increase rather than decrease
contact with primary care providers after diagnosis which continues through the first 5 years
after cancer diagnosis. (Dobie, Saver, Wang, Green, & Baldwin, 2011) However, this still does
not fully explain the reason for lack of survival benefit seen in those with the highest frequency
of office visits. This is an avenue for further research that needs to be explored
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Emergency surgery for CRC can have a significant impact on the progression of the
disease. Predictors of emergency surgery such as race, and tumor location, must be explored
further to avoid the burden associated with the condition. Stage at diagnosis is significantly
associated with emergency surgery; which can be avoided by earlier diagnosis of the cancer.
Further investigation into the association between tumor location and emergency condition for
CRC surgery is warranted.
Diabetes has a poor effect on the survival and all-cause mortality of patients with CRC.
Emergency admission and stage at diagnosis has a large effect on survival and therefore
underscore the importance of early diagnosis. Diabetic patients should be screened and
diagnosed in a timely fashion to prevent CRC or have a better disease prognosis.
This study points to a greater need for further investigation in the differential prevalence
of colorectal tumor location in the elderly. Tumor location in diabetics must be studied further
with a focus on detecting proximal tumors at earlier stages. Future studies should also investigate
use of screening methods and their association with tumor location in the colorectal region and
how it affects outcomes such as survival and mortality.
Current screening guidelines do not consider diabetics as a special case for earlier
screening or more frequent CRC screening. McBean and Yu have reported that elderly diabetic
women are less likely than elderly non-diabetic women to receive colorectal cancer screening in
the 11 SEER areas studied between 1999-2002. (McBean & Yu, 2007) They have furthered the
argument in favor of altering CRC screening guidelines for diabetics by mentioning that the
American Diabetes Association (ADA) should include specific screening recommendation for
such cancers in the Standards of Medical Care in Diabetes. They also suggest combining specific
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recommendations for people with diabetes in guidelines from federal or national organizations
that promote the use of screening services but are not primarily or uniquely concerned with
diabetes such as the CDC, the National Cancer Institute, the American Cancer Society, and the
CMS. An example of such joint advocacy leading to success in the promotion of preventive
services among people with diabetes was the effort to encourage influenza and pneumococcal
immunization. During the 1990s, the CDC, the CMS, and the ADA all stressed that elderly
individuals with diabetes should be vaccinated. As a result, in 2001, rates of influenza and
pneumococcal vaccination were higher in individuals with diabetes 65 years or older compared
with the total elderly population.
Colorectal cancer can be prevented by timely screening. Since diabetic CRC patients
have worse outcomes than their nondiabetic counterparts they must take advantage of this fact
and prevent further burden associated with the disease. Combining the efforts of healthcare
providers, policy makers and intervention strategies the frequency and timeliness of screening
can greatly be improved.
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